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Abstract 
Oxidative stress is a key underlying component in the pathogenesis of retinal 
diseases, including glaucoma, diabetic retinopathy and age related macular 
degeneration (AMD). Intracellular and extracellular anti-oxidants counteract 
oxidative stress to prevent tissue damage and subsequent disease. The 
transcription factor Nrf2 is found in mammalian cells and is a major sensor of 
redox changes. In response to oxidative stress, it activates numerous 
intracellular anti-oxidant enzymes and cytoprotective proteins. Exogenous anti-
oxidants also utilise this pathway to amplify the anti-oxidant response in cells. In 
retinal pigment epithelial cells and photoreceptor cells, the Nrf2 pathway has 
been involved in providing cytoprotection and delaying degeneration within the 
eye. Mueller cells play a supportive role within the retina, protecting the 
surrounding cells from oxidative stress. However, the effects of oxidative stress 
and the Nrf2 pathway have not previously been investigated in retinal Mueller 
cells. In this study, the effects of a range of pro-oxidants and the dietary anti-
oxidant sulforaphane (SFN) on the Nrf2 pathway were investigated in the 
human Mueller MIO-M1 cell line. None of the pro-oxidants investigated, 
including hydrogen peroxide, high glucose concentrations, oxygen and glucose 
deprivation, lipopolysaccharide and TNF-α, activated Nrf2-mediated gene 
expression in MIO-M1 cells. Hydrogen peroxide however, induced the Nrf2-
driven cellular anti-oxidant heme oxygenase-1 (HO-1) in the human ARPE-19 
retinal epithelial cell line In contrast, SFN significantly increased HO-1 and 
NAD(P)H:quinine oxidoreductase 1 (NQO1), but not ferritin or Thioredoxin 
(Trx1) expression in MIO-M1 cells, which are Nrf2 target genes. SFN also 
increased Nrf2 protein expression but not Nrf2 de novo synthesis in MIO-M1 
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cells. SFN-induced Nrf2 and HO-1 expression was dose-dependently 
suppressed by Bisindolylmaleimide I (a protein kinase C inhibitor) and 
LY294002 (a phosphionositide 3-Kinase (PI3K) inhibitor). These results suggest 
that Mueller cells may be more resistant to oxidative stress than other retinal 
cell types and that SFN utilises the Nrf2 pathway to amplify the anti-oxidant 
response in these cells via PI3K and PKC regulation of Nrf2. In conclusion, the 
Nrf2 pathway may have a key role in amplifying neuroprotection in the diseased 
retina through SFN in the Mueller cells.    
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1.1 Function and the Anatomy of the Eye  
 
The eye is an extremely specialized organ; it intercepts light energy and 
transforms it into neuronal signals that the brain processes into visual images. 
Through the eyes, the brain is able to perceive the shapes and colours of the 
visual world.  The human eye is an orbital shaped organ of approximately 2.5 
cm in diameter consisting of different layers, as shown in Figure 1.1, which are 
divided into three sections or tunics: the fibrous coat, the uvea and the neuronal 
layer. The outermost tunic, the fibrous coat, consists of the cornea and sclera. 
The cornea is at the anterior of the eye and has a larger curvature compared to 
the rest of the eye. Its main functions include the refraction of light into the eye, 
transparency to allow light to enter the eye and the ability to protect the eye 
from damage and infection. The conjunctiva is a layer of translucent epithelial 
cells, which covers the cornea, and attaches the eye to the eyelid.  The sclera 
covers the rest of the outer surface of the eye. This is a white fibrous coat made 
of collagen and elastin fibre, which maintains the shape of the eye and protects 
the fragile inner eye. The middle tunic is called the uvea or the uveal tract and 
consists of the choroid, ciliary body and the iris, which are continuous of each 
other. The majority of the uvea consists of the choroid, which is positioned 
between the sclera and the inner retinal layer. Its function includes the 
maintenance and nutrition of the outer layers of the retina and acts as a conduit 
for blood vessels going to other regions of the eye. The ciliary body divides the 
eye into the anterior and posterior regions (Forrester et al 2002).  
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Figure 1.1 Anatomy of the Eye; A labelled cross section of a human eye 
http://user.it.uu.se/~jonasn/drug_delivery_eye.html accessed 2012 
 
The posterior region of the ciliary body named the pars plana originates from 
the choroid at the transition region of the ora serrata. This is the flatter region of 
the ciliary body. The anterior region, known as the pars plicata, extends out into 
the interior of the eye in a triangular shape (Remmington 2005). This region 
contains the ciliary processes, which are responsible for the production of the 
aqueous humour. The aqueous humour is a gel-like viscous liquid. It maintains 
the eyes intraocular pressure and is contained within in the anterior and 
posterior chamber of the eye. The aqueous humour is also responsible for 
providing nutrients and for the removal of waste products of the lens and cornea 
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Figure 1.2. The anterior of the eye. The aqueous humour is produced by the 
ciliary body in the posterior chamber and flows into the anterior chamber. The 
majority of the aqueous humour exits through the canal of Schlemm which is 
drained by the collector channels which leads into the episcleral vein. (Forester 
2002) 
in the anterior chamber. In healthy eyes, the majority of aqueous humour is 
filtered through the trabecular meshwork and exits through the canal of 
Schlemn, which is drained by the collector channels and leads into veins at the 
conjunctiva, as demonstrated in Figure 1.2 (Remmington 2005, Grierson 2002).  
Adjoining the ciliary body is the iris, which is a thin contracting disc that 
separates the posterior and anterior chambers. The iris regulates how much 
light is allowed into the eye by altering the size of the pupil. Directly behind the 
iris is the lens whose primary function is to focus the light on to the retina. This 
is held in place by the lens zonules, which are also connected to the ciliary 
body. Contraction of the ciliary muscle, which forms part of the ciliary body, 
allows the lens to focus. In the central region of the eye is the vitreous humour, 
which is attached to the lens, lens zonule, the ciliary body and the retina 
(Forrester et al 2002). 
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Central Retina
Macular
Fovea Optic Nerve
Figure 1.3. The different regions of the retina. The retina has different 
regions, which have different concentrations of rod and cone photoreceptors. 
The central retina consists mainly of rod photoreceptors and the macular and 
fovea has cone photoreceptors. The optic nerve is located towards the naval 
cavity. Adapted from www.daviddarling.info/images/fovea.jpg 
The inner most tunic, known as the fundus, includes the retina and its 
components. It is continuous with the optic nerve and situated between the 
choroid and the vitreous (Figure 1.1). Its function is to transform light signals 
into neural information that the brain can process into visual images via the 
optic nerve.   The retina contains different regions within it, as shown in Figure 
1.3.  The central retina is a circular region with a diameter of approximately 5-6 
mm. Cone photoreceptors and several layers of ganglion cells mainly populate 
this region (Forrester et al 2002). Within this section is the macular lutea, which 
has a slight yellow tint due to pigments in this area. There is a higher proportion 
of cones here than in the peripheral regions. The fovea is in the centre of the 
macula and is recognisable by having a concaved formed ridge, which consists 
entirely of cone photoreceptors, it is responsible for sharp central vision 
(Forester et al 2002). 
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Retina Pigmented 
Cells
Rods and Cones
Bipolar Cells
Ganglion Cells
Retinal Neuronal 
Fibre layer
Direction of light
A B 
Figure 1.4. The layers of the retina. (A) The orientation of the layers of the 
retina. (B) A detailed view of the cells in the different layers of the retina 
(Modified from Brash 1951).  
 
 
 The retina consists of several different transverse layers, which separate 
into the outer and inner layers of the retina, as shown in Figure 1.4 A. The 
outermost layer consists of retinal pigment cells, followed by the rods and 
cones, biopiolar cells, ganglion cells and the retinal neuronal fibre layer 
(Forrester et al 2002) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
24 
 
The retinal pigment epithelium (RPE) is not part of the neural retina layer, 
but plays an important role supporting visual function. It is a highly organised 
hexagonal monolayer of cells with a lower regeneration rate than other retinal 
cells that have a multitude of functions including maintaining the attachment of 
the retina. The RPE is a selective permeable barrier between the retina and the 
choroid (Forrester et al 2002). It aids the phagocytosis of rod photoreceptors 
and increases the resolution capacity of the eye by the absorption of light, which 
reduces the occurrence of light scatter. The RPE also plays a major role in the 
storage and transport of metabolites required by the eye (Forrester et al 2002, 
Dunn et al 1996). 
The adjacent cell layer contains the photoreceptors, the rods and cones, 
which transduce photons of light, into neural signals by the process of 
phototransduction. Rods sense contrast, black and white, brightness and 
motions but without fine detail (Forrester et al 2002, Grierson 2002). Three 
different types of cones are involved in transforming colour images. They give 
high spatial resolution and sharpness. There are approximately 125 million rods 
and less than 7 million cones within each eye (Grierson 2002).  The signal is 
then transferred to the bipolar cells, whose cell bodies reside within the inner 
nuclear layer. The primary function of the biopolar cells is to take information 
from the photoreceptors to the ganglion cells (Forester et al 2002). 
Ganglion cells transmit the signal from the eye to the brain via the optic 
nerve.  They form the innermost nucleated layer of the retina. The retinal 
ganglion cells (RGC) axon bundles are separated and are ensheathed by glial 
cells. These bundles form the optic nerve and synapse with the lateral 
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genicalate nucleus of the thalamus within the brain.  Within the brain the 
ganglion cells are myelinated by oligodendrocytes.  There are approximately 1.2 
million ganglion cells per eye. Theoretically, this suggests that there are 100 
rods per ganglion cell and 4-6 cones per ganglion cell (Forrester et al 2002). 
The number of layers of ganglion cell bodies varies within the retina. In the 
centre of the retina, there can be up to seven layers but on the peripheral retina, 
there can be only one layer. There are also several different subtypes of 
ganglion cells. In mammals there are 25 different types, with 18 found in human 
retinas (Forrester et al 2002). Ganglion cells are protected and supported by 
glial cells. There are two different types of glial cells; Mueller cells and 
astrocytes. Mueller cells provide structural support and are found throughout the 
retina with their nuclei located in the middle of the inner nuclear layer (Grierson 
2002, Limb et al 2002). Astrocytes are associated with the small blood vessels 
and their regulation in the inner retina (Grierson 2002). 
 
1.1.1 Mueller Cells 
 
There are approximately 8 to 10 million Mueller cells within each human 
retina. They have many roles in the retina, for example, they provide structural 
support as they span all of the retinal layers (Bringmann et al 2006). In addition, 
they interact and provide parental support to other retinal cell types, for 
example, the feet of the cells are in direct contact with the retinal ganglion cells, 
and surround a column of neurons (Bringmann et al 2009a). They play a vital 
role in enabling neurons to maintain a healthy synaptic function, by providing 
them with trophic substances and removing their metabolic waste (Limb and 
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Jayaram 2010). Mueller cells also guide light to the photoreceptors and buffer 
mechanical deformations within the tissue. In addition, they play a vital role in 
regulating the volume, water and ion homeostasis of the extracellular space, 
and maintaining the inner blood retinal barrier (Bringmann et al 2009a). 
Mueller cells remove excess toxic extracellular glutamate from the inner 
retinal tissue by the Glutamate Aspartate Transporter (GLAST). If this process 
malfunctions it can lead to the apoptosis of retinal ganglion and photoreceptor 
cells and this can result in retinal diseases including glaucoma and diabetic 
retinopathy (Harada et al 2007, Bringmann et al 2009b). Mueller cells regulate 
excess extracellular potassium within the retina through the potassium channel 
sub family known as Kir channels, especially via Kir4.1 and Kir2 (Bringmann et 
al  2003). These channels can decrease in function as a person ages and can 
be one of many factors leading to individuals becoming more susceptible to 
age-related retinal diseases (Bringmann et al 2003). 
Mueller cells can be activated by a large and varied range of pathogenic 
stimuli, including, anoxia, hypoglycaemia and ischemia (Bringmann et al 2006). 
Upon activation, Mueller cells have a dual action that is yet to be fully 
understood, as they can be both neuroprotective and also contribute to 
neuronal degeneration; this activation is known as gliosis (Bringmann et al 
2009a). This is a physiological mechanism designed to protect the retina from 
receiving more damage and promote tissue repair without tissue remodelling. 
Gliosis involves biochemical, physiological and morphological changes 
depending on the type and seriousness of the damage and/or insult (Bringmann 
et al 2006). A major and measurable sign of gliosis activation is the upregulation 
of glial fibrillary acidic protein (GFAP) and vimentin, which are intermediate 
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filaments and identifiable markers of Mueller cells. Mueller cells that under 
gliosis activation can proliferate, de-differentiate and increase in volume 
(Bringmann et al 2009a) 
 Mueller cells also aid in the modulation of inflammatory and immune 
responses. They release cytotoxic factors when the retina is subjected to 
Chemokine (C-C motif) ligand 2 (CCL2), also known as monocyte 
chemoattractant protein 1 (MCP-1), which recruits phagocytic cells of myeloid 
origin including microglial cells, monocytes and macrophages to the damaged 
area. This leads to the release of reactive oxygen species and cytokines, 
causing death to surrounding retinal cells (Nakazawa et al 2007). Upon 
activation Mueller cells also release the pro-inflammatory cytokine tumour 
necrosis factor-α (TNF-α) and vascular endothelial growth factor (VEGF) a 
hypoxia induced factor which stimulates the growth of new blood vessels (Tezel 
et al 2001, Wang et al 2010). These and other vascular factors play a role in 
several neurodegenerative eye diseases, including a form of age-related 
macular degeneration (AMD) and diabetic retinopathy (DR). Mueller cells may 
contribute to the development of abnormal vascular physiologies in diseased 
states (Wang et al 2010). 
When the retina is in a diseased or damaged state Mueller cells also 
protect neuronal cells from cell death by secreting neurotrophic growth factors 
and antioxidants such as basic fibroblast growth factor (bFGF) and glutathione, 
respectively. This dual role of being protective and toxic is yet to be fully 
understood, but it may be related to the intensity of gliosis activation, with a 
higher activation of gliosis being more likely to result in neuronal degradation 
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compared to low levels of activation of gliosis being associated with 
cytoprotection (Bringmann et al 2006, Bringmann et al 2009a). 
 Mueller cells have also been reported to have stem cell like properties, 
which are dormant until the retina is subjected to injury, for example retinal 
detachment (Limb and Jayaram 2010). When this occurs, a population or sub-
population of Mueller cells de-differentiate into retinal progenitor cells, which 
express neuronal and photoreceptor proteins. This is a relatively new area of 
research which is focusing on using this population for potential therapeutic 
regeneration of damaged retinas (Lawrence et al 2007). The majority of 
research conducted into Mueller cells thus far has been restricted to animal 
models and cultured Mueller cells; there have been no reports to date on 
human Mueller cells in situ.   
 
1.2  Diseases of the Eye 
      Several different chronic diseases affect the eye; many, if left untreated will 
lead to a level of blindness. Most chronic eye disorders are more prevalent in 
the elderly and as the UK have an increasing aging population, more people will 
be affected.  Treatments are limited and therefore an understanding of the 
pathologies of these diseases is required to identify new therapeutic targets.  
 
1.2.1 Cataracts 
     The major cause of blindness worldwide is cataracts (Pascolini and Mariotti 
2012).  Cataracts can occur naturally as a part of the aging process, leaving the 
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lens with a yellow tinge or a cloudy mass, which can severely impair an 
individual’s vision. In the UK, more than 50% of individuals over 65 have some 
form of cataract in one or both eyes (NHS Choices 2012). The lens becomes 
opaque, which blocks light from reaching the retina. Other types of cataracts 
can also occur, including; paediatric cataracts where an infant is born with the 
condition, diabetes related cataracts and UV damage related cataracts, where 
oxidative stress is a factor. In modern medicine, surgical removal of the cataract 
and the insertion of a new lens into the eye is a simple and quick procedure, 
which allows the patient’s sight to be restored. However, this can still leave post 
operational complications including retinal detachments and posterior capsular 
bag tears (Varma et al 2011, Grierson 2002). 
 
1.2.2 Age related macular degeneration 
Age related macular degeneration (AMD) is a group of diseases which 
affect the macular region of the retina, resulting in the gradual loss of colour and 
central vision. The macula has a high concentration of cones, which are 
responsible for the colour and sharpness of images. As this disease 
progresses, the layers underneath the retina, including the RPE layer, are 
affected (Ambati and Fowler 2012). AMD can be early or late stage depending 
on the amount of damage that has occurred in the macular region. An 
individual’s reading ability can be affected as the central vision is partially or 
completely lost. Objects that normally appear straight can be interpreted to be 
wavy by the patient.  AMD is more prevalent in older people, with approximately 
30% of the UK population aged over 75 having early symptoms of AMD and 7% 
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with more severe symptoms. In 2011, approximately 239,000 individuals in the 
UK suffered visual impairment caused by AMD (NHS Choices 2012). It is more 
common in women compared to men, possibly due to women generally having 
a longer lifespan than men (Evans et al 2004). Many factors have been 
associated with the aetiology of AMD, including oxidative stress, smoking, UV 
light, high blood cholesterol levels, high blood pressure, obesity and genetic 
makeup (Liang and Godley 2003, Bertram et al 2009, Cano et al 2010).   
There are two main types of AMD, dry and wet AMD. Dry AMD affects 
eyes gradually, over many years, and accounts for 90% of all AMD cases and 
there is no current treatment available. In dry AMD there is atrophy of the RPE 
layer with cellular debris developing known as drusens. Wet macular 
degeneration can develop more rapidly and is more serious than dry AMD. 
Within two years of diagnosis, 70% of patients with wet AMD have lost a 
significant amount of their central vision. In wet AMD there is growth of 
abnormal blood vessels which leak blood and fluid into the retina, this is known 
as choroidal neovascularisation. Unlike dry AMD, there are several treatments 
available to treat wet AMD, which can slow down the rate of degeneration and 
in some cases restore some of the lost sight. However, the effectiveness of the 
treatments relies on them being given within the early stages of disease 
progression. VEGF is a cytokine released by Mueller and other cells, which 
stimulates the formation of new blood vessels. Recent therapies have targeted 
VEGF using antibodies (Witmer et al 2003). These include Macugen, Avastin 
and Lucentis and are aimed at reducing the vascular effects seen in AMD (NHS 
Choices 2012). Laser Surgery, also known as photodynamic therapy, is another 
treatment option for wet AMD. This involves injecting the patient intravenously 
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with a dye that collects in the newly forming abnormal blood vessels within the 
retina and then using a low power cold laser to seal off the highlighted blood 
vessels. Hot lasers have also been used, however, this is not preferred as it can 
cause damage to the surrounding healthy retinal tissue (Ambati et al 2012).  
 
1.2.3 Glaucoma 
 
Glaucoma is a group of progressive neurodegenerative diseases of the 
optic nerve that result in apoptosis of the RGC. This leads to a reduction in the 
visual field and a specific pattern of irreversible damage to the optic nerve 
(Weinreb and Khaw 2004, Ritch 2007).  The majority of individuals affected are 
older people. Opticians will actively test and monitor for signs of the disease in 
anyone over the age of 40. By 2020 it is predicted that 79.6 million people 
worldwide will be affected by a type of glaucoma. It is more common in 
individuals of Black-African or Black-Caribbean origins (Quigley and Broman 
2006). It is often asymptomatic to the individual as peripheral vision is first 
affected and it is not until the central vision diminishes that the patient seeks 
professional help.  Visual field tests and visual images of the retina often allow 
for a confirmation of the diagnosis by measuring the cup ratio of the retina. The 
cup enlarges due to the thinning of the neuroretinal rim and excavation of the 
optic nerve heads (Weinreb 2007). If the cup ratio is above 0.7 it is indicative of 
glaucoma. Several factors are thought to play a role in the aetiology of 
glaucoma, including raised intraocular pressure (IOP), oxidative stress, age, 
and genetics (Weinreb and Khaw 2004).   
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      Primary Open Angled Glaucoma (POAG) is the most common type of 
glaucoma. POAG progresses slowly, often without noticeable symptoms, 
resulting in a delayed diagnosis. Over 58 million people worldwide are predicted 
to become affected by POAG by 2020 and approximately 480,000 individuals in 
England are currently affected (NHS Choices Quigley, 2006). In Caucasian 
Europeans 1 in 50 aged above 40 years old and 1 in 10 above 75 years are 
affected  2012 (Quigley and Broman 2006). POAG is more prevalent in 
individuals of African and Latin American origins. It also occurs more in women 
than in men, like AMD this may be due to women living for longer (Quigley and 
Broman 2006). In this type of the disease, the angle between the iris and 
cornea, which is important in aqueous humour drainage, is open as normal, 
meaning the IOP does not increase rapidly, as in acute closure glaucoma, but 
gradually.  All current treatments of POAG are focused on reducing the IOP with 
a combination of medical and surgical approaches (Weinreb 2004).      
There are a range of different eye drops, which work through different 
mechanisms that reduce IOP. Beta-blockers reduce IOP by reducing the rate of 
production of aqueous humour by the ciliary body. Prostaglandin analogues 
reduce IOP by increasing the outflow of the aqueous humour via the 
uveoscleral pathway. However, these drugs can often result in loss of 
pigmentation from the iris. Drugs that target adrenoreceptors, including 
dipovefrine and brimonidine reduce IOP by reducing the production rate of the 
aqueous humour as well as increasing its outflow. Carbonic anhydrase 
inhibitors like acetzolamide, brizolamide, and dorzolamide reduce IOP by 
reducing the aqueous humour production (Mincione et al 2008). 
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There are different surgical and laser treatments available including 
trabeculectomy. In this procedure an alternative route for the aqueous humour 
is created to increase its outflow. Often surgery has to be repeated due to the 
eye’s ability to heal. Anti-wound healing drugs are used to prevent the 
trabeculectomy from healing. Even if the medication and surgery are successful 
in reducing the IOP, it can often increase later. Furthermore once the IOP has 
been brought into the normal range, glaucoma can continue to progress. This 
combined with the fact that glaucoma can occur with patients with normal IOP 
and the limited success rates of the current treatments available suggests that 
there is a  need for  research to be done into other potential mechanisms of 
glaucoma, resulting in better treatments for patients (Weinreb 2007; Vasudevan 
et al 2011).  
In acute angle closure glaucoma the angle between the iris and cornea is 
narrowed, which induces a sudden increase in intraocular pressure (IOP). This 
causes the eye to become painful and red, resulting in damage to the RGCs. It 
is less common than POAG, affecting 1 in 1000 white individuals and 1 in 100 
individuals from Asian origins in the UK (NHS Choices 2012). Immediate 
medical attention is required to prevent permanent loss of sight. Medication can 
be administered as a temporary solution until an iridectomy can be performed. 
This laser surgery results in a direct flow of aqueous humour being created 
between the posterior and anterior chambers (Grierson 2002).  
Other forms of glaucoma include secondary glaucoma, a result of other 
eye conditions that can cause a rise in the IOP within the eye. This can lead to 
damage in the retina that ultimately results in glaucoma.  Causes include a wide 
range of diseases including cataracts and uveitis. Congenital glaucoma occurs 
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when an infant has inherited the disease. Normal Pressure Glaucoma (open 
angled) is where the IOP is not elevated but cupping and loss of sight occurs 
(Harada et al 2007). 
1.2.4 Diabetic Retinopathy  
 
Diabetic retinopathy is a vascular disease of the retina which affects both 
eyes of an affected individual. Chronic high glucose concentrations and 
glycated proteins and oxidative stress cause abnormal changes in the 
microvessels of the retina, causing swelling and leaking eventually resulting in 
blindness (Crosby-Nwaobi et al 2012). There are four different stages in 
diabetic retinopathy, all of which can appear symptomless to the sufferer; these 
are mild, moderate, severe non-proliferative and severe proliferative 
retinopathy. In mild non-proliferative retinopathy, microaneurysms occur in the 
small blood vessels of the retina. The disease progresses when some of the 
blood vessels become blocked. In severe non-proliferative retinopathy several 
blood vessels are blocked, disrupting the blood flow to multiple areas of the 
retina. At this stage the retina tries to compensate by growing new blood 
vessels in the affected areas.  This is a symptom of the final stage of the 
disease, proliferative retinopathy. The new blood vessels which grow along the 
surface of the retina and vitreous are always abnormal, weak and fragile. This 
leads to them leaking blood which causes the deterioration in vision and 
potentially blindness (Grierson 2002). If one of the blood vessels leaks in the 
area of the macular swelling, blurred vision can occur and result in macular 
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oedema. Whilst this can occur at any stage of this disease, it has a higher 
probability of occurring during the latter stages (Hatef et al 2011). 
Individuals with either type 1 or type 2 diabetes are at risk of developing 
diabetic retinopathy, with the risk increasing the longer the individual suffers 
with from the disease. Gestational diabetes also increases the risk of 
developing this condition (Golbert and Campos 2008). 
Regular eye examinations are required for individuals who have 
diabetes, as this can significantly reduce the risk of blindness due to the proper 
treatment and care being administered. No treatment is given for the first three 
stages of the disease. However, surgical procedures are used in macular 
oedema and proliferative retinopathy.  The key to slowing down the progression 
of the first three stages of this disease is by managing the individuals blood 
pressure, blood glucose, and cholesterol levels (Forrester et al 2002). Poor 
management leads to a more rapid progression of the disease. Proliferative 
retinopathy is treated by scatter laser surgery, which helps to shrink the 
abnormal blood vessels by placing between 1000-2000 laser hits to the para 
macular and peripheral retina over two to three treatments. The risk of this 
treatment is a loss of peripheral, colour and night vision and this treatment is 
only effective if administered before multiple bleeds occur. If several bleeds 
have occurred, a vitrectomy may be performed to remove the excess blood 
from the eye (Grierson 2002). Macular oedema is also treated by laser surgery, 
with the laser treatment given in one session burning around the macular 
region, which reduces bleeds and excess fluid and blood within the retina. This 
procedure has a high success rate in reducing the loss of an individual’s sight. 
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Drugs that may be used in treating macular oedema include Lucentis, Avastin, 
Aylea and steroid injections (Hatef et al 2001) 
All of the ocular diseases described above occur more commonly in older 
people. One of the common factors in the pathogenesis of these diseases is 
oxidative stress. The eye is susceptible to oxidative stress, which is 
counterbalanced by anti-oxidants. During the aging process, it is thought that 
the ability to counteract oxidative stress diminishes. Without a defence against 
oxidative stress, the eye is more susceptible to neurodegenerative diseases 
which ultimately will lead to blindness. Understanding the role of oxidative 
stress within the eye and the mechanism that the eye has evolved to counteract 
oxidative stress is imperative to be able to enhance protection for eyes in a 
diseased state (Liang and Godley 2003; Jarrett and Boulton 2012). 
 
1.4  Oxidative stress 
Oxidative stress is caused by the production of reactive oxygen species 
(ROS). These are molecules that contain oxygen and are highly reactive. They 
can either be a free radical, where the species in question has one or more 
unpaired electrons, an oxidising reagent like hydrogen peroxide, or a species in 
a higher energy level like singlet oxygen (Bell et al 2011). They occur naturally 
within the body due to oxygen metabolism, cell respiration, cell signalling and 
other homeostatic processes. ROS can be produced in all cells, particularly in 
the mitochondria, leading to damaged DNA. High levels of oxidative stress can 
lead to the DNA, proteins and lipids of cells being damaged. However, there is a 
mechanism in place to counteract the effects of oxidative stress. Antioxidants 
are able to scavenge free radicals, decrease localised oxygen and through 
37 
 
different pathways inhibit oxidative stress. These antioxidants can are found in 
the diet and include vitamins C, E and flavonioids within the body such as anti-
oxidant enzymes that are found in all cells (Eastwood 1999).     
Several environmental factors can increase the levels of ROS in the eye, 
leading to oxidative stress and tissue damage. Since the eye is directly exposed 
to the environment, it is unsurprising that ROS cause damage in the eye and 
play a role in the pathogenesis of eye diseases (Sacca and Izzotti 2008, Varma 
et al 2011, Zhao et al 2011). In addition to ocular diseases, oxidative stress is 
associated with the pathogenesis of many other chronic age-related disorders 
including cardiovascular diseases, cancer, osteoporosis, arthritis and 
neurodegenerative diseases (Kim et al 2010). 
The eye has one of the highest consumption rates of oxygen within the 
human body (Yu and Cringle 2005). The retina has a very high metabolic rate, 
the highest levels being in the RPE and the photoreceptors, which have a 
correlating high blood supply from the choroid. The inner retina has a slightly 
lower metabolic rate compared to the outer retina and is supplied by the retinal 
circulation (Forrester et al 2002). It is an organ where its function causes a high 
production of ROS, especially in the lens and in the fundus. This is due to the 
eye being exposed to UV and visual light exposure and because of the 
metabolism of polyunsaturated fatty acids contained within photoreceptors. 
When this is increased by environmental and external influences, it can lead to 
a state of oxidative stress and the resulting damage can be a contributing factor 
to eye diseases (Varma et al 2011). 
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 1.3.1 Oxidative Stress stimuli and the eye. 
   
        Many different factors that play a role in the pathogenesis of eye diseases 
induce oxidative stress in the retina. These include increased intraocular 
pressure, glutamate, high glucose concentrations, advanced glycation end 
products, oxygen glucose deprivation (OGD)/ ischemic reperfusion, hydrogen 
peroxide, TNFα and lipopolysaccharide (LPS) (Flammer et al 2002, Gülgün 
2008, Bordone et al 2012). 
TNF-α is a pro-inflammatory cytokine that increases in neurons following 
ischemic attacks within the brain and therefore has been associated with 
neurodegenerative retinal diseases. TNF-α has been linked to the axonal 
degeneration and glial changes observed in the optic nerves of patients with 
AIDS (Scholz et al 2003). It also causes RGC death in glaucomatous retinas. 
TNF-α and TNF-α receptor 1 have found to be more prevalent in glaucomatous 
optic nerve heads in human donor eyes (Yan et al 2000). TNF-α induces 
apoptotic cell death through the TNF-α receptor -1 in a caspase mediated 
pathway. In primary co cultures with RGC and glial cells ischemia and 
increased pressure caused glial cells to release TNF-α, inducing RGC death, 
which was reduced by a TNF-α inhibitor (Fuchs et al 2005, Gülgün 2008, Tezel 
2008). 
 LPS is an endotoxin from the outer membrane of gram negative bacteria. 
In the eye LPS plays a central role in the pathogenesis of uveitis (Kalariya et al 
2012). In humans, LPS binds with LPS-binding protein, CD14 and the toll like 
receptor 4 (TLR4). LPS triggers a cascade of pro-inflammatory cytokines and 
other factors that result in an inflammatory response (Guha and Mackman 
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2001). LPS also induces ROS, resulting in oxidative stress in cells (Rushworth 
et al 2008).  
Glutamate is the primary excitatory neurotransmitter in many retinal cell 
types including photoreceptors, biopolar and ganglion cells (Thoreson and 
Witkovsky 1999). However excessive levels of glutamate have been linked with 
neuronal and retinal ganglion cell death in vivo and in vitro. In 1957 Lucas et al 
first reported the toxic effect of high glutamate on the mammalian eye (Lucas 
1957). Toxic levels of glutamate have been linked to several retinal diseases 
including glaucoma and diabetic retinopathy (Naskar et al. 2000).  Young mice 
injected with glutamate demonstrated destruction of the inner retinal layers 
including the RGC. Injections of glutamate into adult albino rats also resulted in 
the degradation of ganglion and inner nuclear layers. An over stimulation of the 
glutamate receptor N-methyl-D-aspartate (NMDA) has been associated with 
causing increased intracellular calcium levels, leading to apoptosis.  Non NMDA 
receptors have also been associated with glutamate neural degeneration within 
the retina. It is still unclear what leads to glutamate levels increasing to toxic 
levels in the retina; it may be an over load or a failure in the retinas glutamate 
reuptake and transporter (GLAST) mechanisms, which are still not fully 
understood.  It is possible that that when RGC die they release intracellular 
concentrations of glutamate into the surrounding area, causing a cascade of 
glutamate toxicity. Drugs like memantine, an NMDA inhibitor, have been shown 
to inhibit the toxic effects of glutamate (Mansoor et al 2010).  
Oxygen and glucose deprivation (OGD) with reperfusion is another 
stimulus that induces ROS and this has been carried out experimentally in vitro 
and in vivo (Tanaka et al 2007, Danilov et al 2009, Wang et al 2012).  Mueller 
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cells may provide protection in OGD reperfusion episodes; these cells may be 
able to resist the effect of OGD insults more than other cell types in the retina, 
such as RGC (Bringmann et al 2009a). Glucose is required for the normal 
function of the retina and the majority of it is sourced from blood. The abnormal 
glucose levels caused by diabetes affect the eyes’ ability to function. High blood 
glucose concentrations (hyperglycemia) are associated with the progression of 
the vascular component of diabetic retinopathy and cause neuronal 
degeneration within the retina. The biochemical changes that are induced by 
hyperglycemia result in higher levels of oxidative stress. In Mueller cells high 
glucose can stimulate the production of matrix metalloproteinases (MMPs), a 
family of proteins which can degrade the extra cellar matrix (Miyata et al 2012).  
As mentioned above oxidative stress and the production of ROS are 
counteracted by anti-oxidants, which may be exogenous, (such as those 
derived from diet), or endogenous, which are produced by every cell type in the 
body. The transcription factor NF-E2 related factor 2 (Nrf2) is a major sensor of 
oxidative stress in cells and responds by activating cellular anti-oxidants to 
counteract cell damage. Both oxidative stimuli and extracellular anti-oxidants 
can activate this pathway to induce or amplify cytoprotective and anti-oxidative 
responses in cells. Nrf2 is thought to play a key role in protecting the eye and 
retinal cells from oxidative stress-associated damage (Yanagawa et al 2005).  
 
1.4 The Nrf2 pathway 
 
  Nrf2 is a widely conserved protein across the animal kingdom with 
homologues found in nematodes, flies, fish and mammals. It is a 605 amino 
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acid protein that belongs to the Cap’N’ Collar (CNC) family (Moi et al 1994).  
This CNC structure allows binding to small musculoapotneurotic fibrosarcoma 
proteins (sMAF) and to the antioxidant response element (ARE), an enhancer 
element in the regulatory regions of anti-oxidants and other cytoprotective 
proteins.  Other mammalian family members include p45, NF-E2, Nrf1, Nrf3, 
Bach1 and Bach2 (Motohashi and Yamamoto 2004).  Most of these enhance 
transcription when bound to the regulatory regions of target genes. However, 
Bach1 and Bach2 lack transcriptional activation domains and repress 
transcription (Oyake et al 1996)  
Numerous pro-oxidative stimuli have been reported to activate the Nrf2 
pathway, including heavy metals and toxins, pro-inflammatory stimuli, ischemia 
reperfusion, hypoxia, LPS and TNF-α (Tanaka et al 2007, White et al 2010, 
Sethy et al 2011). In addition, anti-oxidants utilize the pathway to amplify their 
anti-oxidant response within cells (Rushworth et al 2011).  
Nrf2 regulates hundreds of genes that play a protective role in the cell 
(Lee and Johnson 2004). These include antioxidant enzymes such as catalase, 
superoxide dismutase,  and heme oxygenase-1 (HO-1), metal-binding proteins 
including ferritin and metallothioneins, NADPH regenerating enzymes, Phase II 
detoxification enzymes including NAD(P)H:quinine oxidoreductase 1 (NQO1)   
and NAD(P)H:quinine oxidoreductase 2  (NQO2), glutathione-regulating 
enzymes Thioredoxin (Trx1) and Thioredoxin Reductase-1. Nrf2 also regulates 
itself, which may allow for more expression of Nrf2 once the pathway is 
activated (Johnson et al 2004, Tanito et al 2007).   
      The exact regulation of the Nrf2 pathway is not fully understood. Whilst the 
basic principles of the pathway are shown in Figure 1.6, certain aspects are still 
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under research. Nrf2 is inactive when bound to a homodimer of Keap1, a 
cytoplasmic inhibitor of Nrf2.  Upon activation by oxidative stress or other 
stimuli, the Keap1/Nrf2 interaction is disrupted, resulting in Nrf2 moving into the 
nucleus and binding to a specific sequence on target genes. All of the genes 
regulated by this pathway have a 5’-flanking cis acting regulatory element 
sequence known as the antioxidant regulatory element (ARE) (Johnson et al 
2004, Motohashi and Yamamoto 2004). The core ARE sequence has been 
identified as 5’TGACnnnGCA-3 and was first found in the rat glutathione S-
transferase Yα subunit gene (Rushmore and Pickett 1990, Rushmore et al 
1991)  Other target genes include antioxidants, Phase II enzymes and other 
cytoprotective proteins that are then upregulated, which aids the protection of 
the cell. The Nrf2 pathway has been found to be upregulated and associated 
with several long-term chronic diseases, which include glaucoma (POAG) 
(Motohashi and Yamamoto 2004, Vargas et al 2008, Nguyen et al 2009). 
 
 
 
 
 
 
 
Figure 1.5 The Nrf2 domains and their interactions.  There are 6 functional 
domains of Nrf2 depicted as Nrf2-ECH homology (Neh).  
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     Nrf2 has six different functional domains known as Nrf2-ECH homology 
domains (Neh 1-6) Neh1 has a basic region-leucine zipper motif and a 
heterodimerisation domain that interacts with the small Mafs and binds to DNA 
as a hetreodimer. Neh2 interacts with Keap1 and is the negative regulatory 
domain (Itoh et al 1999). Currently there are several different theories on the 
exact interaction between these two proteins. However, Neh2 does contain two 
motifs where Keap1 heterodimers are known to interact. These are known as 
DLG and ETG (Tong et al 2006). Neh3 binds to the chromo-ATPase/helicase 
DNA binding protein family member CHD6, which is a transcriptional co-
activator that promotes transcription of ARE-dependant genes (Nioi et al 2005). 
Neh4 and Neh5 together bind the transcription co-activator CBP. CBP is a 
cAMP-response-element binding protein (CREB) binding protein (Katoh et al 
2001). The Neh6 domain controls the Keap1-dependent negative regulation of 
Nrf2 (McMahon 2004). 
Nrf2 is tightly regulated in cells to enable the pathway to respond rapidly 
to oxidative stress. Levels of free Nrf2 are regulated by Keap1, which 
continually targets it for degradation by the 26S proteasome (Zhang 2006). 
Kelch-like ECH-associated protein 1 (Keap1) is an actin-binding cytoplasmic 
protein (Itoh et al 1999). Keap1 covers a cysteine rich sequence on Nrf2, which 
is then degraded by ubiquitination. Bound to Keap1 is the Cullin3-Ring-box 
protien-1-ubiquitin ligase complex (Cul3-Rbx1-E3) complex which helps target 
Nrf2 for ubiquitination degradation (Zhang et al 2004, Kaspar et al 2009).   
Keap1 was identified as the main negative regulatory protein for Nrf2 by in vivo 
data from keap1-deficient mice. Without it mice produced unregulated amounts 
of NQO1 and had major physiological problems and died a few days after birth 
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(Wakabayashi et al 2003).  The domains that have been identified in Keap1 are 
the N-terminal region (NTR), the Broad-Complex, Tramtrack and Bric à Brac 
(BTB) and the Intervening Region (IVR), the double glycine repeat (DGR), 
which is also known as the Kelch domain and the C-terminal region (CTR) 
(Figure 1.6). The functions of these domains are still subject to much research. 
The BTB domain has been shown to form homodimers and heterodimers. The 
Kelch domain is named after the Drosophila egg-chamber regulatory protein 
Kelch and it interacts with the Neh2 domain of Nrf2 in the cytoplasm and is also 
attached to the actin cytoskeleton. The Kelch domain consists of 6 repeats of 
the Kelch motif which forms a 6 bladed β-propeller (Li et al 2004, Tong et al 
2006,  Baird and Dinkova-Kostova 2011). 
 
 
 
 
 
 
 
 
Figure 1.6 Keap1 domains and interactions. The domains are the  N-terminal 
region (NTR), the Broad-Complex, Tramtrack and Bric à Brac (BTB) and the 
Intervening Region (IVR), the double glycine repeat (DGR), which is also known 
as the Kelch domain and the C-terminal region (CTR). 
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1.4.1 Nrf2 regulation 
 
       The exact mechanism by which Nrf2 is activated is still under investigation. 
There have are several pathways and intermediates associated with Nrf2 
activation reported which include the ERK and p38 mitogen-activated protein 
kinases, a phosphoinositide 3-kinase (PI3K), and protein kinase C (PKC) (Keum 
et al 2006).  
PKC is a large family multifunctional cyclic nucleotide independent 
protein kinases that phosphorylates serine and threonine residues in many 
target proteins. They have a key role in a broad range of cellular function 
through signalling transduction pathways including activation in cell proliferation, 
vasoconstriction, secretion and cell shape and volume. The PKC are able to 
have this broad range of functional effect through the different isoforms of PKC 
(Liu 2003). There are currently 11 different  mammalian isoforms of PKC 
identified, divided into 3 different sub classes known as conventional, novel and 
atypical. The conventional PKCs consist of the isoforms α, βI, βII and γ and are 
activated by calcium and diacylglycerol (DAG) and phorbol esters. The novel 
PKC isoforms are ε, δ, η, and θ and are regulated by DAG and phorbol esters 
but not calcium. The atypical PKCs include ζ, λ and ι and are not activated by 
calcium, DAG or phorbol esters (Webb et al 2000).   
PI3K is a kinase which is activated by a variety of cell surface receptors 
including tyrosine kinase receptors and is involved in intracellular signalling 
pathways. It is involved in a wide range of cellular processes including cell 
proliferation, cell migration, protein synthesis and metabolism. PI3K 
phosphorylates inositol phospholipids at the 3rd position of the inositol ring  
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Vanhaesebroeck et al 1997). There are three different sub classes of PI3K 
which are divided depending on the substrate specificity. Class I PI3K 
phosphorylates Phosphatidylinositol, Phosphatidylinositol 4,5-bisphosphate and 
Phosphatidylinositol -4-P and has a catalytic subunit of 11 to  120 kDa. Class II 
PI3K only phosphorylates Phosphatidylinositol and Phosphatidylinositol -4-P 
and Class III PI3K only react with Phosphatidylinositol (Vanhaesebroeck et al 
1997). 
In our laboratory, we have shown that PKC regulates Nrf2 or HO-1 
expression by LPS, curcumin and epicatechin gallate (Rushworth et al 2006). 
Results suggest that LPS induction is mediated by a classical form of PKC, 
whereas upregulation by the dietary anti-oxidants may be mediated by 
PKC(Rushworth et al 2006, White et al 2010). How these different pathways 
interact to cause Nrf2 activation is unknown and is still under investigation. For 
example in response to the anti-oxidant tert-Butylhydroquinone (tBHQ) PKC has 
been reported to phosphorylate Nrf2 on Ser40, leading to dissociation from 
Keap1 and subsequent Nrf2 activation in HepG2 cells (Huang et al  2000, 
Huang et al 2002, Bloom and Jaiswal 2003). Nrf2 driven HO-1 expression has 
been upregulated in primary rat vascular smooth muscle cells by the plant 
extract oleanolic acid via the PI3K/Akt and ERK pathways and Nrf2 ability to 
decrease pigment-related molecules was regulated by PI3K (Huang et al 2000, 
Huang et al 2002, Rushworth et al 2006, Angeloni et al 2011, Feng et al 2011, 
Shin et al 2011). 
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Figure 1.7 A schematic of the Nrf2 pathway. This depicts the current view of 
the Nrf2 pathway. (A) The unstimulated pathway. (B)T he stimulated pathway  
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     Much evidence has accumulated about Nrf2 pathway that suggests it plays a 
major role in the anti-oxidant response in cells (Nguyen et al. 2009). In addition, 
Nrf2 knockout models have demonstrated its importance as an anti-
inflammatory mediator, in a range of chronic inflammatory disease models 
(Thimmulappa et al 2006, Zhao et al 2011). There is still a lack of knowledge on 
the exact mechanisms of this pathway and the roles it could potentially play in 
several different diseases. Understanding the roles of Nrf2 driven genes is 
essential for maintaining a level of cytoprotection in healthy and diseased cells, 
tissues and organs. There are many Nrf2-ARE regulated genes with many 
different functions including efflux proteins like bile salt efflux pump and 
multidrug resistance-associated proteins, peroxiredoxins such as sulfiredoxin 1, 
xenobiotics  including carboxylesterases and phase II enzymes and 
antioxidants like Trx1, HO-1, NQO1 and enzymes involved in regulating 
glutathione synthesis (Klaassen and Reisman 2010, Baird and Dinkova-Kostova 
2011). 
 
1.5 Genes targeted by Nrf2 
1.5.1 HO-1 
Heme oxygenase is the rate limiting enzyme within the heme catabolism 
pathway resulting in the formation of biliverdin, carbon dioxide and iron (Maines 
and Gibbs 2005). Biliverdin (which is metabolised to bilirubin by biliverdin 
reductase) functions primarily to scavenge peroxyl radicals (Wu et al 1991). CO 
at high amounts in the body causes death as it has a higher affinity to 
hemoglobin and myoglobin compared to oxygen. However, evidence suggests 
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that low levels of CO have cytoprotective effects within the cell related to anti -
inflammatory and anti- apoptotic effects in ischemic reperfusion injuries (Berne 
et al 2012).   
There have been three different heme oxygenase isoforms identified, the 
inducible heme oxygenase -1 (HO-1) which is also known as heat shock protein 
32, heme oxygenase 2 (HO-2) which is constitutively expressed and heme 
oxygenase 3 (HO-3), which is still being characterised (McCoubrey et al 1997, 
Hayashi et al 2004). HO-1 is ubiquitous and found in detectable levels in many 
tissues (Jeong et al 2005). Induction and expression of HO-1 is associated with 
a strong role in cytoprotection, especially when cells are stressed by oxidative 
stress, inflammation, UV, ischemia, hypoxia, hyperoxia, hyperthermia, and 
radiation, cytokines, endotoxins, heat shock, heavy metals and other 
pathophysical responses involving oxidative stress (Keyse and Tyrrell 1989, 
Keyse and Tyrrell 1990, Terry et al 1998, Motterlini et al 2000, Castilho et al 
2012). It has long been established that HO-1 has anti-oxidative and anti-
inflammatory functions (Maines and Gibbs 2005). Individuals with HO-1 
deficiencies have a higher susceptibility to oxidative stress and an increased 
pro-inflammatory state with high amounts of endothelial damage, which is 
thought  to be caused by TNF-α and interleukin -1β (Terry et al 1998).  
Stimulating HO-1 expression has been suggested to give protection in OGD 
with reperfusion by providing a level of cytoprotection in a various animal and 
cell models (Cao et al 2006, Leonard et al 2006, Shah et al 2007, Sun et al 
2010). 
Studies conducted on HO-1 knockout mice have shown they have 
multiple organ malfunctions including in the lung, heart and liver also the blood 
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system is impaired. Inflammation and oxidative stress levels in the mice are 
also highly raised (Yet et al 1999, Chen-Reotling et al 2005, Tanaka et al 2007) 
 
 
 
 
 
 
 
 
Figure 1.8 The Heme pathway showing the role of heme oxygenase 1. 
 
Induction/activation of HO-1 has been associated with a protective role in a 
large range of different oxidative stress- related disease states. These include 
hypertension, atherosclersosis, diabetes, lung injury, Alzheimer’s disease, renal 
injury, endotoxic shock, transplantation and ischemia reperfusion injury (Tanaka 
et al 2007). In the retina induction of HO-1 has been shown to be protective in 
the retina.  In rats with DR symptoms were given hemin to induce HO-1 
expression which gave cytoprotection to RGC. HO-1 has also been shown to 
give cytoprotection to the retina when induced by cobalt against ischemic injury 
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et al Sun 2010). In ARPE-19 cells curcumin has also been shown to upregulate 
HO-1 and provide cytoprotection against oxidative stress (Woo et al 2012). 
 
1.5.2 Ferritin 
 
Ferritin is an iron sequestering protein that is regulated by Nrf2. Free iron 
can participate in a reaction known as the Fenton reaction (He et al 2007). This 
reaction can cause tissue and membrane damage and can produce one of the 
most damaging types of ROS, a hydroxyl radical. During the metabolism of 
heme, free iron is released. Ferritin works with an ATPase pump to remove iron 
from the cell. The amount of ferritin within a cell is proportionate to the amount 
of free iron within the cell and this is regulated by a post transcriptional 
mechanism (Hahn et al 2004, He et al 2007). The iron regulatory protein binds 
to the iron responsive element, which inhibits the translation of ferritin mRNA. 
Ferritin expression has been reported in several regions of the eye, including 
the inner nuclear layer, the choroid, RGCs and RPE (Hahn et al 2004). There 
are several cell types within the retina that require iron including RPE and 
photoreceptors.  
 
1.5.3 NQO1 
 
The Phase II detoxification enzyme NQO1 is another target of Nrf2, 
which displays anti-oxidant activities (Baird and Dinkova-Kostova 2011).  NQO1 
is a FAD-dependent flavoprotein which can reduce a range of quinines, nitro-
aromatics and azo dyes. It was discovered by Lars Ernster and was first 
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identified as DT-diaphorase (Conover and Ernster 1960). One of the main 
functions of NQO1 is to be an enzyme in a catalytic reaction in a two electron 
reduction of a variety of quinines to the respective hydroquinones by having 
NADPH or NADH as the hydride donor (Dinkova-Kostova and Talalay 2010). 
NQO1 reduces the opportunity for ROS intermediates to be produced as a 
result of redox cycling and for the depletion of intracellular sulfhydryl pools.  
Other NQO1 functions include its ability to scavenge superoxides and the 
stabilisation of microtubules. NQO1 can also stabilise and stop the degradation 
of tumour suppressing proteins such as p53 (Dinkova-Kostova and Talalay 
2010,  Park et al 2011). NQO1 has been reported to be expressed in RPE cells. 
Pro-oxidative chemicals from cigarette smoke and the exogenous anti-oxidants 
vitamin E and eriodictyol (a citrus flavoniod) have been shown to induce NQO1 
expression in RPE cell cultures (Cano et al 2010). 
 
1.5.4 Thioredoxin 1 
 
     The redox enzyme thioredoxin 1 (Trx1) is also regulated by Nrf2.  Trx1 is a 
13 kDa ubiquitous protein, which is found in organisms from yeast to mammals 
(Zhong et al 2000).  In the presence of ROS, its two redox-active cysteine 
residues (-Cys-Gly-Pro-Cys-) become oxidised (Holmgren 1985, Zhong et al 
2000). Once Trx1 has been oxidised it can be reduced back to its active form 
via Thioredoxin reductase, another Nrf2-regulated enzyme, with the aid of 
NADPH. Other functions of Trx1 include the protection of neuronal cells from 
ischemia reperfusion, reduction of protein disulfides, and protection from 
hypoxia during birth (Bertini et al 1999). It has also been reported to aid the 
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regulation of specific transcription factors and play a role in DNA synthesis. Trx1 
expression has been detected in photoreceptor cells and RPE cells in the 
retina, where it protects these cells from light damage (Tanito et al 2005). 
 
 
 
 
 
 
 
Figure 1.9 Reaction of Thioredoxin, Thioredoxin reductase with NAPDH 
returns Thioredoxin to its reduced state so it can provide protective effects 
within the cell.  
 
1.5.5 Glutathione  
 
Glutathione (GSH) is the major cellular anti-oxidant found in cells as it is 
found in millimolar concentrations. Several enzymes regulate glutathione 
synthesis and metabolism and many of these are regulated by Nrf2 (Lu 2009). 
They include glutathione S-transferase (GST), glutathione synthase (GS) 
glutathione reductase (GR) and glutathione cysteine ligase (GCL). GCL is the 
rate-limiting enzyme in glutathione biosynthesis. GSH is a substrate in reduction 
and conjugation reactions in cells, and these reactions are catalysed by GST.  
Glutathione is maintained in a reduced state in cells by the action of GR and 
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presence of NADPH, which allows the cells to maintain a reduced and healthy 
state (Wu and Juurlink 2001, Lu 2009). Glutathione has been reported to be 
present and protective in the retina. Low glutathione S-transferase (GST) 
expression has been reported in retinas from patients with glaucoma (Tezel 
2006). 
 
1.6 Nrf2 pathway activation by exogenous anti-oxidants 
 As discussed, the Nrf2 pathway can be activated by several stresses and 
pro-oxidative stimuli. It can also be activated by several natural products that 
possess anti-oxidant properties that utilities the pathway to amplify their 
antioxidant response in cells and tissues. For example in THP-1 cells α-lipoic 
acid from tomatoes, curcumin from turmeric and resveratrol from grapes been 
shown to induce HO-1 mRNA expression in THP-1 cells (Ogborne et al 2004, 
Rushworth et al 2006, Wang et al 2011). Curcumin also increased Nrf2 driven 
expression of GCL, in immortalized human bronchial epithelial (HBE1) cells 90 
(Dickinson et al 2003). Resveratrol also has induced NQO1 expression in 
Hepa1c1c7 cells and HO-1 expression in rat pheochromocytoma (PC12) (Chen 
et al 2005, Park et al 2011).  Caffeic acid phenethyl ester (CAPE) is derived 
from bee’s honey and in rat renal epithelial cells induced Nrf2 driven HO-1 
expression (Balogun et al 2003). Another well characterised compound from 
broccoli is sulforaphane  
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1.6.1 Sulforaphane (SFN) 
 
      Isothiocyanates are organosulphur compounds, which are characterised by 
a sulphur containing N=C=S functional group and are found in various 
cruciferous vegetables. They include allyl isothiocyanates found in cabbage, 
mustard and horseradish, phenethyl isothiocyanate from watercress and garden 
cress and SFN from broccoli, cauliflower, watercress and kale. SFN exists in 
the vegetables in the precursor form of a thioglucoside, which in broccoli is 
known as glucoraphanin. Glucoraphanin, like all glucosinolates is not bioactive 
until hydrolysed into sulforaphane, an indole-3 carbinol, a reaction that is 
catalysed by myrosinase (Zhang et al 1992, Danilov et al 2009, Keum 2011). 
This enzyme reaction occurs when the vegetable is disrupted either by 
harvesting, processing or chewing. 
Figure 1.10 Activation of SFN. The inactive glucoraphanin is converted into 
SFN by myrosinase which is activated by chewing and the microflora of the gut 
(Keum 2011).  
SFN has been found to have a broad spectrum of protective properties in 
several tissues, including anti-oxidant, anti-inflammatory, anti apoptotic, and 
chemopreventive effects (Juge et al 2007). It also activates the Nrf2 pathway, 
although the exact mechanism leading to this activation is unclear. SFN may 
disrupt the Nrf2 and Keap 1 interaction by modifying Cys151 on Keap1, allowing 
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newly synthesised Nrf2 to accumulate and translocate into the nucleus. SFN 
may also interact with other reactive thiol groups on Keap 1, including Cys257, 
Cys273, Cys28, which then leads to activation of Nrf2 (Zhang and Hannink 
2003). However kinases upstream of Nrf2 have also been implicated in Nrf2 
regulation (Keum et al 2006). 
SFN has generally been shown to be a strong activator of Nrf2- regulated 
phase II genes, including NQO1 and GST in a wide variety of tissues in 
mammals, including kidney, prostrate, colon, pancreas, liver and eye. In relation 
to the eye, SFN has been shown to activate the Nrf2 pathway and specific 
downstream target genes to provide cytoprotection. Microglial activation in the 
retina is associated with several disease processes. Yang et al. reported that 
SFN inhibited the effects of LPS-induced retinal microglial activation through a 
p38 MAPK-dependent mechanism. p38 mitogen-activated protein kinase is a 
part of the MAPK family. p38-MAPK is a part of a pathway which aids the 
relaying of extracellular signals and stimulations, often cytokines and cellular 
stress, to intracellular responses through phosphorylation of MAPK (Roux and 
Blenis 2004, Yang et al 2007). SFN has also been reported to protect RPE cells 
from a lipofuscin pigment via NQO1 and GST (Zhou et al 2006). SFN induced 
GSH and the enzymes that regulate it in the human ARPE-19 cell line, including 
GCL, GS and GR. Wang et al demonstrated that SFN-induced glutathione and 
GCL were regulated by Phosphoinositide 3-Kinase (PI3K) (Shapiro et al 2001, 
Wang et al 2008). PI3K is a family of kinases which Talalay et al showed that in 
the presence of UV stress SFN upregulated GCL and NQO1 expression in 
ARPE-19 cells (Gao and Talalay 2004). Interestingly, whilst HO-1 has been 
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shown to be upregulated by SFN in the liver, kidneys and skin, HO-1 has not 
been induced by SFN within the retina.  
 The Mueller cells are of key interest in the progression of retinal 
diseases. Further understanding into their role and function in the diseased and 
healthy retina is essential. How oxidative stress and antioxidants affect these 
cells and other cell types, including the RPE, and by which mechanisms needs 
to be fully understood. The Nrf2 pathway is a good candidate by which 
neuroprotection can be provided within these cells. 
 
 
 
1.7 Aims of this study 
 
To investigate  
(A) The effects of oxidative stress inducers on anti-oxidant gene expression 
in Mueller cells.  
(B) The effects of the antioxidant SFN on the Nrf2 pathway in MIO-M1 cells 
and examine the mechanism involved. 
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Chapter 2 
Material and Methods 
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2.1 General Reagents  
 
LY 294002, Bisindolymaleimide 1,     Lipopolysaccharide E.coli O111:B4 
(LPS) and MG-132 were all obtained from Calbiochem, (Nottingham UK). All 
plastic consumables were obtained from Fisher (Loughborough UK). The 96® 
AQ AQueous One Solution Cell Proliferation Assay was from Promega 
Southampton, H2O2, and BSA were all obtained from Sigma-Aldrich, (Poole, UK) 
Sulforaphane was purchased from LKT Laboratories, Inc, Germany.  D-Glucose 
was obtained from Fisher Scientific (Loughborough, UK) Human TNF-α was 
purchased from R&D systems, Abingdon. Unless otherwise stated, all other 
reagents were obtained from Invitrogen (Paisley UK). 
  
2.2 Cell culture 
 
2.2.1 Reagents 
 
DMEM/F-12, RPMI 1640, DMEM glucose free medium, DMEM + 
GlutaMAX, L-Glutamine 2mM, penicillin 10000 units/mL, streptomycin 
10000µg/mL, 0.25% Trypsin-ethylenediaminetetraacetic (EDTA) were all  from 
Invitrogen. 10% fetal calf serum (FCS)  was obtained from Biosera, (S.America 
Origin). 0.25% Trypsin-ethylenediaminetetraacetic (EDTA), Eagle’s minimum 
essential medium (EMEM),  50 μg/mL gentamycin, 0.4% Trypan blue solution 
and sodium bicarbonate were all obtained from Sigma-Aldrich, (Poole, UK).  
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2.2.2 Heat inactivation of FCS 
 
 FCS was heated to 56°C for 45 min in a water bath and then aliquoted 
into 50 mL aliquots and stored at -20°C. 
  
2.2.3 Cell Lines 
 
2.2.3.1 THP-1 
 
THP-1 cells are a human monocytic leukemic cell line derived from the 
blood of a boy with acute monocytic leukaemia (Tsuchiya et al 1980). They 
were obtained from the European Collection of Cell Cultures (ECACC). They 
have been previously validated in the laboratory as a model of human 
monocytes. These cells were cultured in RPMI 1640 media with penicillin (100 
units/mL) and streptomycin (100µg/mL), 2 mM L-glutamine and 10% FCS. The 
cells were passaged biweekly at 3.5 days apart by counting the cells, removing 
the appropriate cells and media and adding media so that they were kept in the 
range of 2.5 and 6×105 cells/mL and were used between passages 3-30. Cells 
were maintained in a humidified atmosphere at 37°C, 5% CO2. 
 
2.2.3.2 MIO-M1  
 
 The Moorfields/Institute of Ophthalmology-Müller 1 cell line (MIO-M1) is 
a spontaneously immortalised human Mueller cell line, which was a kind 
donation from Dr A. Limb at the University College London’s Institute of 
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Ophthalmology (Limb et al. 2002). These cells were cultured in DMEM medium 
with Glutamax, 10% FCS, penicillin (100 units/mL) and streptomycin (100 
µg/mL).  
Confluent cells were passaged by removing the complete media and 
washing with 5 mL of warmed PBS. This was removed and 5 mL of warmed 
0.25% trypsin EDTA was added for 3 to 4 min at room temperature to detach 
the cells from the flask. The trypsin was neutralised with complete media and 
the cells were counted. Cells were then centrifuged at 800 rpm for 8 min. The 
supernatant was removed and the cell pellets were resuspended in 10 mL of 
complete medium. Cells were passaged 1/5 every seven days, fed every 3.5 
days and maintained between 5x104 and 2.5x105 at 37°C , 5% CO2.  
 
2.2.3.3 ARPE-19 
 
 ARPE-19 is a human retinal pigment epithelial (RPE) cell line which 
arose spontaneously from a primary culture of RPE cells from a male donor 
(Dunn et al. 1996).The cells were purchased from the American Type Culture 
Collection (ATCC) and cultured in DMEM/F12 with 10% FCS, 0.15% Sodium 
Bicarbonate 2 mM L-Glutamine and penicillin (100 units/ mL) and streptomycin 
(100 µg/mL). The cells were trypsinised as above and split 1/10, fed every 3.5 
days and maintained between 5x104 and 2.5x105 at 37°C, 5% CO2. 
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2.2.4 Counting Cells 
Cells were counted using a Neubauer haemacytometer (Fisher). 20 µL of 
cells was mixed with 80 µL of 0.4% Trypan blue solution to make a 1/5 dilution. 
The cells were counted using the grid on the haemocytometer. The mean 
number of cells was calculated and this was multiplied by the dilution factor and 
then by 104 to scale the volume of the haemocytometer (0.1 mm3) to cells/mL.  
This calculation is summarised in the figure below. 
                             mean x dilution factor x 104 = number of cells/mL 
 
2.2.5 Cryopreservation   
 
The ARPE-19 were frozen down by trypsinising the cells as described 
above, centrifuging at 400 rpm for 5 min and resuspending in freezing media 
consisting of 10% cell culture grade DMSO and 90% filter sterilised FCS. The 
MIO-M1 cells  were trypsinised as described above and were resuspended in 1 
mL of freezing media which consisted of 10% cell culture grade DMSO, 50% 
GlutaMax Media and 40% filter sterilised FCS. Approximately 2.5 million cells 
were put into one cryovial in 1 mL of freezing media. This was placed on ice 
and then frozen at -80°C before being stored long term in liquid nitrogen.   
Cells were thawed by defrosting the cells, which were then transferred to 
eppendorfs and centrifuged into a pellet at 400 rpm for 5 min. The freezing 
medium was removed and the cells were resuspended in 10 mL of complete 
medium, placed into a T75 flask and maintained at 37°C, 5% CO2. For adherent 
cells, the media was changed the next day once cells had attached.  
2.3. Stimulations  
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Cells and tissues were treated with a range of stimuli and inhibitors for 
various times.  
 
2.3.1 LPS 
 
 A stock concentration of 5 mg/mL of Lipopolysaccharide E.coli O111:B4 
(LPS) (Calbiochem) was made by adding 1 mL of 37°C RPMI media to 5 mg 
LPS powder and was vortexed for 5 min before being heated for 5 min in a 37°C 
water bath and then vortexing again for 2 min. The heating and vortexing was 
repeated 4 times and then the LPS were aliquoted into 4 labelled eppendorfs, 
wrapped with parafilm (Parafilm® M, Sigma Aldrich) and stored at -20°C. 
 
2.3.2 TNF-α 
 
Human recombinant TNF-α (R&D systems) was made into a stock 
concentration of 10 µg/mL. Human TNF-α was used at a final concentration of 
10 ng/mL.   
 
2.3.4 Sulforaphane 
 
Sulforaphane (LKT Laboratiories, Inc) was made into a 100 mM stock by 
adding 1410 µL cell culture grade DMSO to 25 mg of Sulforaphane (SFN) and 
mixed well. A final concentration of 1-10 µM of SFN was added to the cells for 
various amounts of time, depending on the experiment.  
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2.3.4 H2O2 
 
 A stock concentration of 200 mM H2O2 (Fisher) was made with 21.3 µL 
9.4 M H2O2 into 978.7 µL sterile dPBS, which was stored at 2-8°C. A final 
concentration of 200 µM was used for various periods of time depending on the 
experiment. 
 
2.3.5 Glucose 
 
A stock concentration of 25 M was made with 450.4 mg of D-Glucose 
(Fisher) in 1mL of warmed sterile dPBS. This was vortexed and heated to 
ensure that the glucose was fully dissolved. The glucose was used within 7 
days of being made. Glucose was used at varying times at a final concentration 
of 25 mM. 
 
2.3.6 Oxygen and Glucose Deprivation 
 
Cells were seeded in 35 mm dishes at 10000 cells per well and left for 4 
days to grow 90% confluent. Cells were then serum starved for 24 h with DMEM 
medium with Glutamax, penicillin (100 units/mL) and streptomycin (100 µg/mL). 
To initiate the experiment ,the cells which were going into the ischemia chamber 
had their media changed into DMEM glucose free medium supplemented with 
penicillin (100 units/mL) and streptomycin (100 µg/mL)  which had been starved 
of oxygen by bubbling 95% N2 and 5% CO2, from a cylinder, through the 
medium for 10 min. The Modular Incubator chamber (Billups-rothenberg Inc) 
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(Wolf Laboratories Limited, York UK) was used to recreate ischemic conditions. 
Once the cells had been sealed into the chamber using the attached metal ring, 
it was filled with 95% N2 and 5% CO2 by connecting directly to a cylinder via a 
tube for 10 min to flush out the atmospheric oxygen and create anaerobic 
conditions. The tubes were then sealed off and the chamber was incubated at 
37°C for either 50 min or 1 h and 50 min, depending on the experiment. The 
cells were then removed from the chamber and the anaerobic media was 
replaced by the serum starved medium. The cells were then reperfused for 
varying amounts of time. The controls to this experiment were subjected to the 
media changes as in the test conditions but instead of anaerobic media, the 
controls had DMEM glucose free medium supplemented with penicillin (100 
units/mL) and streptomycin (100 µg/mL) and they were not placed within the 
chamber but incubated at 37°C with 5% CO2 for either 50 min or 1 h and 50 
min. 
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2.4 Inhibitors 
 
2.4.1 LY 294002 
 
 LY 294002 (Calbiochem) was made into a stock concentration of 50 mM 
in DMSO. This inhibitor was incubated with the cells at various concentrations 
between 1 and 25 µM  for 30 min preincubation before the adding of another 
stimulus. 
 
 
2.4.2 Bisindolymaleimide 1 
 
Bisindolymaleimide 1 (BIS1) (Calbiochem) was made into a stock 
concentration of 50 mM in DMSO. This inhibitor was incubated with the cells at 
various concentrations between 1 and 10 µM for 30 min pre- incubation before 
the adding of another stimulus. 
 
2.5 MTS cell viability assay 
 
The MTS assay used the 96® AQueous One Solution Cell Proliferation 
Assay. This is a colourimetric method used to quantify the number of viable 
cells within a sample. This reagent contains 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, which is a MTS 
tetrazolium compound, and an electron coupling reagent (phenazine 
ethosulfate; PES) which increases the stability of the solution. The MTS 
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tetrazolium compound is converted into a coloured formazan product by cells 
that are viable. The viable cells achieve this conversion by NADPH or NADH 
produced by dehydrogenase enzymes in the mitochondria. The level of 
mitochondrial activity is an early indicator of cell death of damage. The amount 
of formazan produced is directly proportional to the amount of viable cells.  
Formazan compound can be measured by an absorbance at 490nm.  
 
.  
 
 
 
 
 
 
Figure 2.1 Reaction in the MTS assay. The MTS tetrazolium compound is 
converted into the formazan product in viable cells. The amount of formazan 
that is produced is directly proportional to the amount of viable cells within the 
sample which can be read at the absorbance of 490nm. 
(www.promega.com/tbs/tb245/tb245.pdf) 
 
Cells were seeded in a 96 well plate in 100 µL of media at varying 
seeding concentrations incubated at 37°C with 5% CO2 for 4 days to achieve 
confluent cells. The outer wells of the plate were never used for cell seeding but 
were filled with 200 µL of water to prevent evaporation. Cells were then serum 
starved for 24 h.  Following various stimulations and incubations after the 
relative stimulations and incubations, 10 µL of Cell titer 96 AQueous One Solution 
Reagent (Promega) was added to each well and incubated in darkness at 37°C 
with 5% CO2 for 2.5 h. The plates were then read on a BMG Labtech FLUOstar 
OPTIMA microplate reader at 492 nm.  All controls and test conditions were 
carried out in triplicate on a 96 well plate. Controls included untreated cells, 
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serum starved cells and vector controls of compounds added to the cells. A 
blank consisting of media was taken away from the measured absorbances and 
the mean of the triplicates was calculated. By comparing the measurement to 
controls in the same test conditions the percentage cell viability was calculated. 
 
2.6 Real-Time (RT) Quantitative PCR 
 
2.6.1 Reagents 
 
RT reagents were from Applied Biosystems, the TriReagant Solution 
from Ambion and the designed primers from Invitrogen. All other reagents were 
obtained from Sigma Aldrich.  
 
2.6.2 Cell Lysis 
 
Adherent cells were seeded in 35 mm dishes in 2 mL of media at varying 
seeding concentrations incubated at 37°C with 5% CO2 for 4 days to achieve 
confluent cells. Cells were then serum starved and after the required 
experiments the cells were lysed using 1 mL TriReagant Solution (Ambion). 
After 5 min cells were then scraped and solution placed into labelled 
eppendorfs. The samples were then frozen at -80°C until RNA extraction was 
performed. 
Suspended cells were seeded 16 h prior to the first stimulation in 24 well 
plates at 5×105 cells/mL in 2 mL of media and left to rest for 16 h over night prior 
to the first stimulation. After the required experiments the cells were placed in 
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labelled eppendorfs and centrifuged at 200 rpm for 5 min to pellet the cells. The 
medium was then removed and the cells were resuspended in 1 mL of 
TriReagant Solution. The mixtures were pipetted up and down 10 times to 
ensure the cells were lysed and left at room temperature for 5 min. The samples 
were then frozen at -80°C until RNA extraction was performed.  
 
2.6.3 RNA extraction 
 
Samples were fully defrosted and 100 µL of 1-bromo-3-chloropropane 
(BCP) was added to each sample and inverted for 10 seconds and then left for 
10 min at room temperature. The samples were then centrifuged at 12000 -g for 
20 min at 4°C. The upper phase was removed into a fresh eppendorf tube and 
mixed with 500 µL of isopropanol. This was vortexed for 10 seconds and rested 
for 10 min at room temperature. The sample was centrifuged for 15 min at 
12000 -g at 4°C. The supernatant was then removed and the pellet was washed 
in 1 mL of ethanol and spun at 7500 -g for 12 min at 4°C. The ethanol was then 
removed and the pellets left to air dry at room temperature. The RNA was then 
dissolved in RNA free water and stored at -80°C.  
 
2.6.4 RNA quantification 
 
The RNA samples were fully defrosted and 1 µL of RNA solution was 
placed on to a Thermoscientific Nanodrop machine which had been blanked 
with RNA-free water (Fisher Scientific). The quantified samples were diluted so 
that the range of RNA was between 100 and 200 ng/mL. RNA gives an 
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absorbance reading at 260 nm. The Nanodrop also gives a reading which 
indicates the purity of the RNA sample. The ratio of absorbance at 260/280 
indicates if there is any DNA contamination. This ratio ideally should be 2.0 with 
RNA samples. This research aimed for a ratio between 1.8 and 2.0, as varying 
compositions of nucleotides can affect this ratio. Lower values than this could 
indicate phenol or protein contamination which absorbs at 280 nm.  The 
260/230 ratio is a secondary measure of RNA purity, ideally the ratio should be 
2.0, however although lower ratios can indicate contamination this ratio is not 
an accurate measure of contamination as the 260/280 ratio.  
 
2.6.5 cDNA synthesis 
 
Quantified RNA was diluted with RNA-free water to make equivalent 
amounts of cDNA in each sample. The total volume was made up to 4.5 µL. 
This was achieved by adding the same amount of RNA per sample to 5.5 µL of 
Master mix (Applied Biosystems, Roche) which included mixture of 2.5 µL 
MgCl2 (25µM), 1 µL 10× random hexamers, 0.25 µL Reverse Transcriptase 
buffer, 0.25 µL of RNAase Inhibitor and 1 µL of 2.5 µM dNTPs and 4 µL H2O. 
This 10 µL mixture was placed in a thermocycler PCR for 40 min which had the 
repeated cycle of 10 min at 21°C, 15 min at 42°C, 5 min at 99°C and 5 min at 
4°C. This allows for the RNA with the Master Mixture to be converted into cDNA 
ready to be used for qRT-PCR. A control without the Master Mix, (replaced with 
water), and a control with the Master Mix without the Reverse Transcriptase, 
(replaced with water), were added to each run to ensure no amplification of 
RNA contamination. cDNA samples were stored at -80°C. 
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2.6.6 qRT-PCR 
 
qRT-PCR is a system which uses fluorescent quantification of specific 
mRNA transcripts which have been converted into cDNA as described in 2.7.5.    
qRT-PCR was executed with guidance taken from the Minimum Information for 
Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines  
outlined in Bustin et al 2009 which specify the best options for standardising 
qRT-PCR data (Bustin et al 2009).  
Primers were designed using the Universal Probe Library (Roche). For a 
list of primers see Table 2.1. When designing the primers, the following 
considerations were taken into account;  the primers were approximately 20 
nucleotides in length;  the nucleotides content consisted of 50% GC; the melting 
points for the forward and reverse primers were similar;  the primers did not 
form unwanted secondary structures on themselves;  no primer-dimers greater 
than 6 base pairs between each primer and itself and also between the two 
primers;  the forward and reverse primers were about 500 base pairs apart; and 
the 3’ end of the primer should be a G or a C (Qiagen). 
 
 
 
 
 
 
 
 
72 
 
Table 2.1 Forward and reverse primers used 
Name Forward Primer Reverse Primer 
Nrf2 
5’-AAC CAC CCT GAA AGC 
ACA GC-3’ 
5’-TGA AAT GCC GGA GTC 
AGA ATC-3’ 
hNQO1 
5’-CGC AGA CCT  TGT GAT 
ATT CCA G-3’ 
5’-TTC TAT GAA CAC TCG 
CTC AAA CC-3’ 
hHO-1 
5’-ATG GCC TCC CTG TAC 
CAC ATC-3’ 
5’-TGT TGC GCT CAA TCT 
CCT CCT-3’ 
Heavy 
Chain 
Ferritin 
5’-AAC AAC GAG GTG GTG 
GCC-3’ 
5’-TTC AGC CCG CTC TCC 
CAG T-3’ 
GAPDH 
5’-AAC AGC CTC AAG ATC 
ATC AGC A-3’ 
5’-TGC TAA GCA GTT GGT 
GGT GC-3’ 
Thioredoxin 
reductase 
5’-GGG CAA TTT ATT GGT 
CCT CA-3’ 
5’-GGT CCT TCA CCA GTG 
GCA AT-3’ 
β-actin 
5’-GCT CTT TTC CAG CCT 
TCC T-3’ 
5’-CGG ATG TCA ACG TCA 
CAC TT-3’ 
 
GAPDH was used as a housekeeping gene to normalise the gene of 
interest, as it is not affected by the conditions of the experiment. For each 
sample tested, for the gene of interest and the housekeeping gene, 5 µL of the 
cDNA sample was placed into a tube and mixed with 10 µL SYBR Green, 4 µL 
water and 1 µL of a mix of front and reversed primers at 5 µM that related to the 
specific gene of interest to make a total solution of 20 µL per sample. The 
SYBR green consists of 20 mM Tris-HCl pH 8.3, 100mM KCl, 7 mM MgCl2, 0.4 
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mM dNTP (dATP, dCTP, dGTP, and cTTP), stabilisers, 0.05unit/µL Taq DNA 
polymerase, Jumpstart Antibody and SYBR green 1.  Five standards for each 
gene used were made from a mix of the total cDNA for analysis purposes; this 
was carried out by doing a serial dilution with RNAase free water, giving known 
relative concentrations of 1, 0.5, 0.25, 0.125 and 0.0625. The samples were run 
on the Qiagen Rotorgene Q machine for 40 cycles that consisted of 15 seconds 
at 95°C, 60 seconds at 40°C. A melting curve was also run for each primer in 
each experiment.   
 
2.6.7 Analysis 
 
Rotor-Gene Q series Software 1.7 was used to record the data from the 
Qiagen PCR machine. From this, CT values used were taken from the 
exponential region of the amplification and by using the standard curve the 
concentrations of the RNA of the experiment were calculated. The standard 
curve efficiency ideally should be 1 and a range of 0.85 to 1.15 was generally 
accepted, the R and R2 values also had to be within 0.99 and 1. The gene of 
interest calculated concentrations were normalised against the housekeeping 
genes calculated concentrations. The house keeping gene CT values were 
within 1 standard deviation of each other. These normalised results were then 
produced as fold inductions of the experimental control, to show the gene 
expression of interest as normalised fold difference to the control. 
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2.7. Western Blots 
 
2.7.1 Reagents 
 
Unless otherwise stated below all other reagents were obtained from 
Invitrogen. Prestained SDS Page Standards Broadrange Molecular Weight 
Marker and PVDF Membrane was from BIO RAD and the dried milk powder 
was from Marvel. The Methanol, Tris base, NaCl, 5M HCL, Tween-20, Trisbase, 
Triton X-100, NaCl, 5M HCL, Tween-20, chemiluminescent reagent ECL, 
SuperSignal chemiluminescent reagent and CL-XPosureTM Film Clear blue X-
Ray film were all obtained from Fisher. 
 
2.7.2 Cell Lysis  
 
Adherent cells were seeded in 35 mm dishes in 2 mL of media at varying 
seeding concentrations and incubated at 37°C with 5% CO2 for 4 days to 
achieve confluent cells. Cells were then serum starved for 24 h and after the 
required experiments, media was removed from the cells and the samples were 
lysed using 100 µL 1× Tris-Glycine SDS sample reducing buffer, diluted with 
dPBS, mixed well and by using a cell scraper were put into labelled eppendorfs. 
The samples were then wrapped in parafilm, and heated to 95°C for 5 min and 
frozen at -20 until required. 
Suspended cells were seeded 16 h prior to the first stimulation in 24 well 
plates at 5×105 cells/mL in 2 mL of media and left to rest for 16 h over night prior 
to the first stimulation. After the required experiments the cells were placed in 
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labelled eppendorfs and centrifuged at 200 rpm for 5 min so the cells were in a 
pellet. The medium was then removed and the cells were resuspended in 100 
µL 1× Tris-Glycine SDS sample reducing buffer and mixed well. The samples 
were then wrapped in parafilm, boiled for 5 min and frozen at -20°C until 
required.  
     
2.7.3 Poly Acrylamide Gel Electrophoresis  
 
Samples were defrosted and 9 µL or 13.5 µL (for MIO-M1 cells only) was 
mixed with 1 µL or 1.5 µL of NuPAGE Reducing Agent respectively at a 1:10 
ratio.  The samples were then vortexed, pulse centrifuged to bring down 
reagents to the bottom of the eppendorfs, wrapped in parafilm and boiled in 
water for 5 min to ensure that the samples were not viscous. The samples were 
then pulse centrifuged again.  
The preset 4-12% Bis-Tris Gel was loaded into an Invitrogen Xcell II Gel 
rig with a Surelock system. 200 mL of running buffer with 500 µL NuPAGE 
Antioxidant was added to the Upper Buffer Chamber.  After ensuring no 
leakages occurred, 400 mL of running buffer was added to the lower chamber. 
Before the samples were loaded the lanes were rinsed out with the running 
buffer. 10 µL of each sample was loaded into the lanes of the gel and 15 µL 
was loaded when using MIO-M1 samples. The gel was loaded from left to right 
using gel loading tips with 5 µL of prestained SDS PAGE Standard Broad 
Range Molecular Marker (Biorad) loaded in the first lane of the gel.  Any empty 
lanes were filled with the same ratio and volume of lysis buffer mixed with PBS. 
The rig was attached to a power 330 Fisher Scientific powerpack and run at 
76 
 
200V for 50 min when the gel loading dye had ran all the way to the foot of the 
gel. 
 
2.7.4 Transfer 
 
The polyvinylidene fluoride (PVDF) membrane was soaked in methanol 
for 30 seconds and  washed in the 1× transfer buffer on a shaker for at least 15 
min. 6 blotting pads were saturated in the 1× transfer buffer for at least 15 min. 
Once the gel electrophoresis had completed it was released from the rig and 
the gel was released from the gel plates. A piece of filter paper the same size 
as the gel soaked in the 1 × transfer buffer was placed directly on top of the gel 
and any air bubbles were removed. The foot and tops of the wells were cut 
away. The gel was then flipped over on to a glass plate and the pre-soaked 
PVDF membrane was placed on the gel. Another pre-soaked filter paper was 
then placed on top of the membrane. Any remaining air bubbles were removed. 
The assembled western sandwich was placed between pre-soaked blotting 
pads and placed into the Invitrogen Blot Module with the gel closest to the 
cathode core. The blot module was then placed into the rinsed Invitrogen X cell 
II. The blot module was filled with the 1× NuPAGE Transfer buffer until the 
gel/membrane assembly was just covered. The outer chamber was filled with 
650 mL ultrapure deionised water. The transfer was run at 30V for 1 h using a 
Power 350 Fisher Scientific powerpack. 
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2.7.5 Staining the Gel 
 
After the transfer the gel was stained to check how well the gel had run. 
The gel was washed three times for 5 min in ultrapure water at room 
temperature on a shaker. The gel was then stained with 20 mL SimplyBlue 
SafeStain for 1 h, this was then poured off and three more 15 min washes with 
deionised water were performed.  
 
2.7.6 Immunoblotting 
 
Once the transfer was complete the PVDF membrane was placed in 
blocker solution for 1 h at room temperature or overnight at 4°C. The primary 
antibody was diluted as stated in Table 2.2 and applied to the PVDF membrane 
for 1 h at room temperature. The membrane was then quickly rinsed in the 1× 
TBST. The membrane was washed in blocker solution three times for 5 min 
each and this was followed by three 5 min TBST washes. Next, the appropriate 
secondary antibody, as shown in Table 2.3, was put into blocker buffer and 
applied to the membrane for 30 min at room temperature. This was followed by 
a quick rinse in 1× TBST buffer then three 5 min washes in blocker and three 5 
min washes in 1× TBST buffer.  
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Table 2.2 Primary Antibodies 
 
Antigen Type Species Dilution Supplier 
HO-1  
Monoclonal 
antibody 
Mouse 1:1000 
 
Stressgen 
 
HO-1 
Polycolonal 
antibody, 
Goat 1:2000 RnD 
Nrf2 
Polycolonal 
antibody 
Rabbit 1:1000 
 
Abcam 
 
β-actin 
Monoclonal 
antibody 
Mouse 
 
1:100000 
 
Sigma 
Aldrich 
 
 
 
Table 2.3 Secondary antibodies 
 
Antigen Type Dilution Supplier 
Goat - Anti 
Mouse  
Monoclonal 
antibody, 
1:1000 Dako 
Goat Anti 
Rabbit 
Polycolonal 
antibody 
1:1000 Santa Cruz 
Donkey Anti 
Goat 
Polycolonal 
antibody 
1:1000 Santa Cruz 
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2.7.7 Developing  
 
2.7.7.1 ECL Reagents 
 
Various methods of development were used throughout this research as 
equipment and resources changed. First, the membrane was developed using 
the chemiluminescent reagent ECL (Pierce) which consisted of two 
chemiluminescent reagents; 1 and 2, 2 mL of each reagent were pipetted into a 
foil covered centrifuge tube, mixed well and kept in subdued light. This was then 
added to the semi-dried membrane for 1 min and the excess was blotted off. 
The membrane was placed between two sheets of acetate membrane and kept 
in the dark. 
SuperSignal chemiluminescent reagent (Pierce) was used using the 
same method as described above as it gave more stable signal for a longer 
period of time. This was applied by spraying the reagent evenly over the 
membrane. 
In later experiments an ECL rapid step spray (Calbiochem) was used. 
This was applied in a light, even covering to the membrane which was then put 
into an acetate sleeve and kept in subdued light.  
 
2.7.7.2 Imaging 
 
Throughout the research two different imaging methods were used as 
different equipment became available. The first involved placing the membrane 
in an acetate envelope into a film cassette. CL-XPosureTM Film Clear blue X-
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Ray film (Thermoscientific) was place into the cassette in total darkness for 
various amounts of time varying from 2 sec to 30 min depending on the level of 
protein expression. This was then place in an X-Ograph X4 imager machine to 
be developed. When developing by the second method, a G box SynGene 
Machine was used by placing the membrane in an acetate envelope into the 
machine and using GeneTools and GeneSnap software to develop and analyse 
the membrane. In all developing methods the molecular weight marker was 
later added to the developed image of the expressed protein of interest. 
 
2.7.8 Stripping Membrane for reuse 
 
The membrane was kept in a fridge in blocking solution until being 
stripped for reuse. 18 mL ddH20 with 2 mL re-blot was mixed together and put 
on the membrane for 30 min on a shaker at room temperature. This was 
followed by three 5 min PBS-T washes. The membrane was then ready for the 
Immunoblotting protocol. 
 
2.7.9 Buffers for Western Blot Analysis  
20× TBST buffer stock solution  
 48.4g Tris base,  
160g NaCl,  
62 mL 5M HCL 
20 mL Tween-20  
1 L of distilled water.  
The pH was adjusted to 7.6.  
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1× TBST buffer solution  
950 mL deionised water  
 50 mL 20 × TBST buffer stock solution 
 
Blocker solution  
20g of dried milk  
400 mL 1X TBST buffer solution and kept at 4°C. 
 
Running Buffer.1× 
1× running buffer consisted of  
760 mL ultrapure deionised water,  
40 mL 20× MOPS SDS  
 
Transfer buffer  
680 mL  deionised water,  
80 mL methanol, 40 mL  
20× Transfer Buffer  
1 mL NuPAGE Antioxidant. 
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2.8. Immunocytochemistry for Cell Cultures 
 
2.8.1 Fixation and Preparation 
 
Adherent cells were grown on sterilised glass slides placed in 35 mm 
dishes. Different cell concentrations were seeded into the dishes and left to 
grow for 4 days. All cell types were fixed in 4% paraformaldehyde at room 
temperature for 30 min. This was followed by three 10 min washes in PBS. The 
fixed samples were stored at 4°C.   
 
2.8.2 Immunoblotting 
 
The fixed cells on slides were blocked in 100 µL blocking solution with 
0.2% Triton X-100 for 90 min at room temperature. The blocking solution was 
gently removed and 100 µL primary antibody diluted in blocking solution (see 
Table 2.3 for dilutions) was added to each sample for 90 min at 37°C. The 
samples were then washed three times for 10 min with blocking solution with 
0.2% Triton X-100. All steps from this stage were done in subdued light 
conditions. 100 µL of the secondary antibody diluted in blocking solution without 
Triton X100 as stated in Table 2.4 was put on the samples for 1 h at 37°C . 
Three 10 min PBS washes were performed before excess moisture on the 
slides was removed and 50 µL PBS + DAPI (1:100 dilution) was placed on each 
tissue sample for 10 min.  Three 10 min washes were then performed before 
the excess moisture was removed again with blue tissue.  A drop of hydromount 
was added to a glass slide and the cover slip was placed on to the glass slide 
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with the cells facing down on to the glass. The samples were then wrapped in 
foil and left in dark conditions overnight at room temperature before being 
stored at 4°C in the dark.  
 
2.8.3 Imaging 
 
The samples were imaged using a Leica Laser Microscope CMS GmbH. 
Images were processed and analysed using the Leica Application Suite and 
compared to the secondary Antibody controls and controls from the 
experimental procedures. 
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Table 2.4 Secondary Antibodies for Immunocytochemistry  
 
Antigen Type Dilution Supplier 
 
Goat Anti 
Mouse IgG 
(H+L) 
AlexaFluor 488 1:1000 
Invitrogen, 
Paisley, UK 
 
Goat Anti  
Mouse IgG 
(H+L) 
AlexaFluor 568 1:1000 
Invitrogen, 
Paisley, UK 
 
Goat-Anti 
Rabbit IgG 
(H+L) 
AlexaFluor 568 1:1000 
 
Invitrogen, 
Paisley, UK 
 
 
 
2.9 Statistical Analysis 
 
One way ANOVA and the secondary Tukey test were applied to all 
results and occasionally an unpaired T- test was applied.  All data were 
calculated and analysed using GraphPad Prism Version 5.00 (GraphPad 
Software, Inc) and Microsoft Office Excel 2007. 
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Chapter 3 
Effect of oxidative stress on antioxidant gene 
expression in human retinal cells 
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3.1 Introduction 
       Mueller and RPE cells play an extremely important role in the retina, 
providing support, growth factors and immunomodulators to the surrounding cell 
types. Mueller cells have a key role in regulating ion and water homeostasis, 
protecting and maintaining the inner blood-retinal barrier (Bringmann et al 
2009b). They interact closely with neurons in the retina, providing them with 
trophic substances and removing their metabolic waste (Limb and Jayaram 
2010). They also aid the survival of photoreceptor and neuronal cells both 
structurally and by modulating immune and inflammatory responses (Bringmann 
et al 2006). These cells have been reported to become activated by a range of 
pathological stimuli, including excess glutamate, oxidative stress, inflammation 
and damage to the retina. This activation is termed gliosis. 
        When Mueller cells undergo gliosis, morphological, biochemical and 
physiological changes occur to protect the retina from incurring damage. The 
upregulation of the Mueller marker GFAP is an early sign of gliosis. Another 
early sign is cell size increase and proliferation with de-differentiation into 
progenitor-like cells (Bringmann et al 2009a). The aim of gliosis is to maintain 
and protect the retina when it is under stress. Whilst low level gliosis activation 
is cytoprotective, high levels of activation have toxic effects which can lead to 
neuronal degradation (Bringman et al 2006). In addition, Mueller cells have 
been reported to activate the immune system when the retina is subjected to 
retinal injury. They can up-regulate inflammatory factors and aid the recruitment 
of immune cells to the affected area of retina which can release cytotoxic 
cytokines and produce ROS, which have a significant role in neuronal 
degeneration after ischemia-reperfusion (Wang et al 2010).  
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         Oxidative stress is a major contributor in the pathogenesis of retinal 
neurodegenerative eye diseases (Tezel 2006, Jarrett and Boulton 2012). 
Exposure to an array of different stimuli can result in oxidative stress, increasing 
ROS within the eye. Potential sources of oxidative stress within the retina 
include oxygen and glucose deprivation (OGD) reperfusion from restricted or 
changed blood flow. Decreased blood flow is proposed to be part of the 
underlying pathophysiological mechanisms of glaucoma (Flammer et al 2002). 
In addition, the high glucose concentrations found in patients with uncontrolled 
diabetes can induce ROS in the retina.  The oxidising agent, H2O2, is a by-
product of oxidative metabolism and has also been shown to be cytotoxic in the 
retina (Liang and Godley 2003). TNF-α and LPS are pro-inflammatory 
mediators which can induce ROS. LPS is an endotoxin from the outer 
membrane of gram negative bacteria and has been shown to be involved in 
uveitis in the eye (Kalariya et al 2012). TNF-α is a cytokine which induces 
apoptotic cell death through the TNF-α receptor-1 in a capase mediated 
pathway and has been shown to be produced by Mueller cells during gliosis, 
which can cause oxidative stress within the retina (Wang et al 2010). It has 
been reported that Mueller cells are more resilient to oxidative stress compared 
to other retinal cell types. Moorfields/Institute of Ophthalmology-Müller 1 cell line 
(MIO-M1) (Figure 3.1A) is a spontaneously immortalised human Mueller cell line 
(Limb et al 2002). 
      Nrf2 is a transcription factor found ubiquitously in all tissues.  Nrf2 
responds to oxidative stress by activating an array of cellular anti-oxidants and 
other cytoprotective proteins (Kaspar et al 2009). HO-1 is a downstream target 
of Nrf2 key in providing cytoprotection and has been shown to be upregulated 
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as a result of oxidative stress in mice retinas and the RPE (Castilho et al 2012). 
It is the rate-limiting enzyme in heme catabolism which metabolises cytotoxic 
heme to bilirubin and CO.  This leads to release of free iron which can lead to 
the ROS, OH′ (the hydroxyl radical) being released in the cell through the 
Fenton reaction (He et al 2007). There is evidence to suggest that patients with 
AMD have excessive iron accumulation within the retina (Hahn et al 2004). 
Ferritin, another Nrf2-driven gene, is an iron sequestering protein that works 
with an ATPase pump to remove free cytosolic iron from the cell. Ferritin has 
been reported to be in the inner nuclear layer, the choroid, RGCs and RPE 
(Gnana-Prakasam et al 2010).  
NQO1 is a Phase II detoxifying enzyme, which is regulated by the Nrf2 
pathway. It reduces ROS intermediates as a result of redox cycling via NADP 
and NADPH (Dinkova-Kostova and Talalay 2010).  NQO1 has been reported to 
be expressed in RPE cells and pro-oxidative chemicals from cigarette smoke 
activate NQO1 expression in ARPE-19 cells (Cano et al 2010). 
Thioredoxin (Trx1) is another cytoprotective protein that helps maintain 
the cell in a reduced state by having two redox-active Cys residues (Bertini et al 
1999). Thioredoxin reductase is the enzyme responsible for taking Trx1 back 
into a reduced state; both Trx1 and thioredoxin reductase are Nrf2 regulated 
genes. Trx1 has been reported to be within the eye and can provide 
cytoprotection against light damage. Trx1 expression has been detected in RPE 
cells and photoreceptor cells (Tanito et al 2005). 
 The Nrf2 pathway has not been reported previously in Mueller cells and 
it is unclear whether this pathway plays a role in the response of these cells to 
oxidative stress. In this study, the effects of OGD and other oxidative stress 
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Figure 3.1  Morphology  of MIO-M1 and ARPE-19 cells.  (A) MIO-M1cells 
and (B)  ARPE-19.  20 × magnification was used.  
A                                              B 
inducers on anti-oxidant gene expression were investigated in the human 
Mueller cell line MIO-M1. Comparisons were also made to the ARPE-19 human 
RPE cell line. 
 
 
 
 
 
 
 
 
 
 
 
3.2 Aim 
 
To investigate the effects of oxidative stress inducers on anti-oxidant gene 
expression in Mueller cells.  
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3.3 Results 
 
3.3.1 The Effects of OGD on Nrf2 driven genes in MIO-M1 cells 
 
 OGD is one of the major inducers of oxidative stress in the retina and 
can affect the viability of retinal cells. Mueller cells were subjected to 1 h OGD 
using a modular incubator chamber followed by 24 h reperfusion. Oxygen levels 
in the medium were measured using an oxygen probe to ensure that they were 
maintained at a very low level during the experiments (Figure 3.2A). The results 
demonstrate that the oxygen levels were reduced from normal saturation levels 
(100%) to none (0%) by bubbling 95% N2 and 5% CO2 gas through the media 
and that the chamber maintained low levels of oxygen throughout 1 h of OGD. 
Cell viability was measured by MTS assay. OGD with 24 h reperfusion induced 
a small but significant proliferation of MIO-M1 cells compared to the control 
(Figure 3.2B), suggesting that MIO-M1 cells are not adversely affected by OGD.  
 
 
 
 
 
 
 
. 
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Ischemia reperfusion has previously been reported to induce HO-1 via 
the Nrf2 pathway in liver and kidney cell lines and in vitro in rat and mouse 
models. The effects of OGD on Nrf2-dependent gene expression were 
investigated. Figure 3.3 (A-D) demonstrates that serum-starved cells subjected 
to OGD with reperfusion for various times (0-16 h) had no significant effect on 
the mRNA levels of Nrf2, NQO1, ferritin or HO-1. However the results do show 
some trends, specifically, NQO1 did increase slightly with OGD induction. The 
effect of OGD on HO-1 protein expression in MIO-M1 cells was also 
investigated.  Figure 3.4 demonstrates that OGD had no effect on HO-1 protein 
expression 
 
Figure 3.2 Effect of OGD on viability of MIO-M1 cells. (A) Verification of OGD 
chamber function.  Levels of oxygen in the media, 100% is the normal saturated 
level, 0% is when the media has been depleted of oxygen and 1 h OGD is the 
levels of oxygen in the media after 1 hr OGD.  (B) Serum starved MIO-M1 cells 
were subjected to 1h OGD with 24 h reperfusion. After the experimental 
conditions MTS was added for 3 h. Absorbance was measured at 490nm. Mean 
+ SEM (n=3) p*<0.05, p**<0.01.    
 
.   
A                                                           B 
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NQO1 
A B 
C D 
Figure 3.3. Effects of OGD and reperfusion on Nrf2-dependent gene 
expression in MIO-M1 cells. MIO-M1 cells had 1 h OGD and 0-16 h 
reperfusion.  (A) HO-1, (B) Nrf2, (C) Ferritin and (D) NQO1 mRNA expression 
was measured by qRT-PCR and normalised to GAPDH mRNA expression. 
Mean + SEM (n=3-4).  
 
 
 
 
 
 
Nrf2 
Ferritin 
HO-1 
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3.3.2 Effects of oxidative stress on HO-1 expression in MIO-M1 and ARPE-
19 cells 
In retinal cells it has been shown that production of oxidative stress stimuli can 
induce expression of HO-1 in human retinal pigment epithelial cells (Bertram et 
al 2009). As there were no major changes with OGD, the effects of a range of 
oxidative stimuli on HO-1 expression in ARPE-19 and MIO-M1 cells was 
investigated. Figure 3.5 displays the effect of different oxidative stimuli on 
expression of HO-1 mRNA in MIO-M1 cells. Serum starved cells were treated 
with either 10 ng/mL TNF-α, 10 µg/mL LPS, 25 mM  high glucose or 100 µM 
H2O2 for 0-12 h. Results were normalised to the level of GAPDH mRNA in the 
cells and the fold induction compared to the control. The TNF-α, LPS and H2O2 
experiments were repeated 4 times and the glucose experiments repeated 3 
times. The result show that TNF-α, LPS, glucose and H2O2 gave no significant 
fold increase induction in HO-1 mRNA expression during the 12 h time course 
(Figure 3.5). However, again, certain trends are noticeable within these results. 
Notably, whilst HO-1 does not give a significant fold increase after treatment 
    Controls reperfusion       OGD reperfusion 
   0    12    16    20    24    0    12    16    20    24       
 
   HO-1                                                                                      32 kDa 
  β-actin                                                                                   42 kDa 
Figure 3.4. OGD does not increase HO-1 protein expression in MIO-M1 
cells.  Cells were untreated or treated with 1 h of OGD and reperfused for 0-24 
h and protein extracts were prepared. HO-1 protein expression was assessed 
by western blot analysis. Figure is a representative of n=3. 
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with H2O2 by a one way ANOVA with a post-hoc Tukey Test, using a student’s t 
test there was a significant difference between 0 and 3 h (p<0.05).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 Effect of oxidative stimuli on HO-1 mRNA expression in MIO-M1 
cells. Serum Starved MIO-M1 cells were treated with 100 µM H2O2 (A), 10 
µg/mL LPS (B), 25 mM Glucose (C) and 10 ng/mL TNF-α (D) for 0-12 h and 
RNA extracts were prepared. HO-1 mRNA expression was measured by qRT-
PCR and normalised to GAPDH mRNA expression. Mean + SEM (n=3/4).  
 
 
LPS 
TNF-α Glucose 
   C                                                            D 
     A                                                              B 
H2O2 
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Sources of oxidative stress have been suggested to increase HO-1 expression 
in ARPE-19 cells. To compare the results from the MIO-M1 oxidative stimuli 
experiments, the same set of oxidative stimuli were used. The effect of different 
oxidative stress stimuli on HO-1 expression in ARPE-19 cells is shown in Figure 
3.6. The serum starved cells were treated with either 10 ng/mL TNF-α, 10 
µg/mL LPS, 25 mM Glucose or 100 µM H2O2 for 0-12 h. All results were 
normalised to GAPDH and the fold induction compared to the control. The result 
show that TNF-α, LPS and Glucose gave no fold induction or trends in HO-1 
expression during the 12 h time course. However, H2O2 did result in a significant 
fold induction in the expression of HO-1 mRNA.  At 3 h the induction was at 21-
fold, which continued to increase to 55-fold at 6 h before reducing to 13-fold by 
12 h.  
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LPS 
TNF-α Glucose 
A                                                                    B 
C                                                                    D 
H2O2 
Figure 3.6. Effects of proinflammatory stimuli on HO-1 mRNA in ARPE-19 
cells. Serum starved ARPE-19 cells were treated with either, 100 µM H2O2 (A), 
10 µg/mL LPS (B), 25 mM Glucose (C) or 10 ng/mL TNF-α (D) for 0-12 h and 
RNA extracts prepared. HO-1 mRNA expression was measured by qRT-PCR 
and normalised to GAPDH mRNA expression. Mean + SEM (n=3/4) 
p***<0.001.  
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The induction by H2O2 in ARPE-19 cells clearly showed that that 
methodology was working. Further positive controls for the other stresses have 
also been carried out within the lab using different models.  A positive control 
carried out as part of this research (Figure 3.7), demonstrates that LPS does 
induce HO-1 in THP-1 cells, a human monocytic leukemic cell line which is a 
well established model for studying the Nrf2 pathway (Tsuchiya et al 1980, 
Ogborne 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7. LPS induction of HO-1 protein expression in THP-1 cells.  
Cells were incubated with 10 µg/mL LPS. Total protein extracts were prepared 
and HO-1 protein expression measured by western blot analysis. 
Representative experiment of n=3.  
  
0      16 
   HO-1                       32 kDa 
  β-actin                      42 kDa 
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3.4 Discussion 
 
     Oxidative stress plays a key role in retinal diseases and in the activation of 
Mueller cells (Bringmann et al 2009b). This novel data found that that whilst 
other cell types respond to oxidative stress stimuli and invoke Nrf2 driven 
genes, the Mueller cell line, MIO-M1, had little response to oxidative stress and 
did not cause a significant upregulation in Nrf2 regulated genes.  It is known 
that Mueller cells have an important role in the protection of neuronal cells 
(Bringmann et al 2009b).  The activated state of gliosis is stimulated by 
pathological stresses and can provide damage limitation in the retina.  However, 
it can also inadvertently have more toxic effects in the retina, depending on the 
level of activation (Bringmann et al 2009a). It may be by this mechanism and 
not Nrf2 that oxidative stress is combated and cytoprotection given. 
       No work has been performed previously on the effect of OGD on the MIO-
M1 cell line. One study investigating hypoxia on primary rat mueller cells for 12 
h found that they showed a transient proliferation and it was only when they 
performed hypoxia for 24 h that cytotoxicity occurred (Zheng et al 2010).  This is 
comparable to the results seen here with OGD, where exposure resulted in a 
small but significant increase in MIO-M1 cell number. Other research has 
increased the intraocular pressure of rat eyes for 60 min to simulate ischemic 
conditions and did find that HO-1 expression was increased in Mueller cells 
which were found to be more resistant to the insult. However, although ischemic 
conditions were confirmed, the increase in IOP could have also triggered other 
mechanisms in the retina that contributed to the increase of HO-1 (Arai-Gaun et 
al 2004). Both these studies commented on the resilience of Mueller cells. OGD 
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has resulted in cytotoxicity in other retinal cell types (RGC, neuronal and RPE 
cells) which seem to be less resistant to cytotoxic effects (Osborne et al 1997, 
Osborne et al 1999). Other models of OGD in the liver and kidney have shown 
that HO-1 is upregulated in the reperfusion period (Tanaka et al 2007).  
Upregulation was not observed in MIO-M1 cells. 
The presented results suggest that whilst OGD in the MIO-M1 causes a 
slight but significant increase in cell viability at 1 h, which could be a sign of 
gliosis,  it was not related to a significant induction of Nrf2, NQO1, ferritin or HO-
1. However, a slight trend for NQO1 and ferritin expression was noted as a 
result of OGD with reperfusion. This suggests the Nrf2 pathway could be 
present in these cells but that it is not the main mechanism by which oxidative 
stress is managed.   However, the resistance to the cytotoxic effects of OGD in 
the MIO-M1 cells is unlikely to be due to the induction of the Nrf2 pathway.   
      The Nrf2 pathway can also be activated by an array of different oxidative 
stresses including TNF-α and LPS in THP-1 cells as shown in Figure 3.16, 
(White et al 2010, Rushworth et al 2011). Saviranta et al demonstrated that HO-
1 can be induced by H2O2. They showed that 1.1 µM H2O2 after 24 h caused 
over 20-fold induction of HO-1 expression in ARPE-19 cells (Saviranta et al 
2011). LPS, TNF-α, Glucose, and H2O2 did not significantly induce HO-1 
expression in the MIO-M1 cells. However LPS did show a potential trend to 
increase HO-1 which may have become significant with a longer time course 
and glucose, a factor in diabetic retinopathy, may have induced a small 
increase of HO-1 expression at 6 h, but this is marginal. LPS, TNF-α and 
Glucose, did not induce HO-1 expression in the ARPE-19. However, a 
significance increase in HO-1 in the MIO-M1 cells was seen in response to 
100 
 
H2O2 at 3 h (Student’s t-test; p<0.05). However, analysis by one way anova, 
with a post-hoc Tukey Test, did not show significance. This suggests that H2O2 
can increase HO-1 expression in the MIO-M1 cells.  It would be important to 
carry out further experiments using different concentrations and time points to 
confirm these results. The effect of H2O2 on HO-1 expression in MIO-M1 cells 
was compared to that in ARPE-19 cells.  The response was much reduced in 
the MIO-M1 cells with 100 µM H2O2 at 6 h giving a 55-fold induction in the 
ARPE-19 cells. This highlights the differences between the MIO-M1 and the 
ARPE-19 cells, despite both having similar roles within the retina in aiding the 
immune response in the retina and producing cytokines. This suggests that the 
MIO-M1 cells have another mechanism by which they are able to provide 
themselves with cytoprotection and deal with oxidative stress. 
       This research clearly demonstrated that the Nrf2 pathway is not the main 
mechanism by which the MIO-M1 cells respond to oxidative stress, however it 
does not conclude by which mechanism MIO-M1 cells do respond. This work 
was all carried out in human cell lines and not animal models in which a lot of 
retinal research is carried out. However, a future direction available may be to 
work directly from human retinal tissue samples. Another line of inquiry could 
include a micro-array approach, scanning the expression of many different 
genes. This technique could be employed to investigate which pathways may 
be involved in providing cytoprotection to MIO-M1 cells when subjected to 
oxidative stress. Another direction of research would be to look at the activation 
of GFAP, which is an early sign of gliosis to investigate if it is by this mechanism 
that Mueller cells cope with oxidative stress. 
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It was novel to find that the MIO-M1 cell line was resistant to many 
oxidative stresses and that the Nrf2 pathway was not majorly involved in 
providing a level of cytoprotection when these cells were subjected to them. 
This meant that investigating the Nrf2 pathway when using oxidative stress as a 
stimulus was not possible and so it was decided not to pursue this direction of 
research further. Instead, it was decided investigate whether the Nrf2 pathway 
could be induced in these cells by stimulating the cells with antioxidants.  
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Chapter 4 
Effects of sulforaphane on Nrf2-mediated gene 
expression in retinal cells 
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4.1 Introduction 
 
 The eye is constantly subjected to oxidative stress caused by UV light 
and other factors (Varma et al 2011).  Oxidative stress can lead to retinal 
damage and is associated with the development of diseases such as cataracts, 
age-related macular degeneration, diabetic retinopathy and glaucoma (Liang 
and Godley 2003) Anti-oxidants are thought to combat oxidative stress and 
protect the eye from damage. Anti-oxidants can be found in the diet and are 
produced endogenously in cells in response to oxidative stress (Ogborne et al 
2004). The transcription factor Nrf2 is a key sensor of oxidative stress and 
responds by activating cellular anti-oxidants and other cytoprotective proteins, 
including HO-1, NQO1 and Trx1 to defend the cell from oxidative stress 
(Motohashi Yamamoto 2004, Kensler et al 2007, Dinkova-Kostova 2010). 
Sulforaphane (SFN, 4-methylsufinylbutyl isothiocyanate), an 
organosulphur compound found in cruciferous vegetables, has been found to 
have various protective properties in several tissues, including anti-oxidant, anti-
inflammatory and chemopreventive effects (Juge et al 2007). SFN exists in 
vegetables in the precursor form of a thioglucoside, which in broccoli is called 
glucoraphanin. Once the vegetable is consumed, this is hydrolysed into SFN by 
the enzyme myrosinase (Keum 2011, Zhang et al 1992).  
SFN has been reported to activate Nrf2 or its downstream target genes 
in various cell types, including work from this laboratory where SFN activated 
HO-1 and NQO1 expression in primary human monocytes (Rushworth et al 
2008). SFN has also been found to induce Nrf2-driven gene expression in 
retinal cells For example, in the ARPE-19 cell line, SFN induces Trx1, HO-1, 
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NQO1 and enzymes involved in regulating GSH synthesis including GCL, GS, 
and GR (Cano et al 2008, Wang et al 2008). SFN has also been reported to 
protect RPE cells from lipofuscin damage via induction of NQO1 and GST 
(Zhou et al 2006). In tubby mice, the retinal Trx1 system is impaired which 
results in photoreceptor degeneration. In this model, SFN can induce Trx1 and 
delay inherited photoreceptor degeneration via the extracellular signal-regulated 
kinase (ERK)/Nrf2 signal cascade (Kong et al 2009).  
HO-1 has been suggested to have cytoprotective roles within the retina, 
and is activated by dietary anti-oxidants including curcumin and 
epigallocatechin via Nrf2 (Rushworth et al 2006, Ogborne et al 2004).  
However, there have been no reports in the literature of SFN activating HO-1 in 
retinal cells.  In addition, to date, the effects of SFN on retinal cells have been 
limited to RPE, microglial, astrocytes and photoreceptor cells (Tanito et al 2005, 
Kong et al 2007, Yang et al 2007, Cano et al 2008). Mueller cells, however, are 
very important in the retina, transversing all layers, and have the dual function 
of being both protective and detrimental in the retina (Grierson 2002, Limb et al 
2002). They also play a key role in response to oxidative stress and damage 
within the retina (Bringmann et al 2009a) 
 
4.2 Aim 
 
To investigate the effect of the antioxidant SFN on the Nrf2 pathway in MIO-M1 
cells and examine the mechanism involved. 
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4.3 Results 
 
4.3.1 The effects of SFN on HO-1 expression in ARPE-19 and MIO-M1 cell 
lines. 
 
MIO-M1 cells were serum-starved for 24 h and then treated with 10 µM 
SFN or vehicle control (DMSO) for 0, 3, 6 and 12 h. HO-1 mRNA expression 
was measured by qRT-PCR and normalised to GAPDH expression. SFN 
significantly increased HO-1 expression in MIO-M1 cells (Figure 4.1). As SFN 
has been previously reported to activate Nrf2-driven gene expression in ARPE-
19 cells, these were used as a control in this study. SFN significantly increased 
HO-1 expression in ARPE-19 cells (Figure 4.1). Both cell types showed the 
same pattern of induction with peaks at 3 h and expression remaining high at 6 
h before the levels of HO-1 mRNA expression decreased at 12 h. As 3 h gave 
the peak of HO-1 expression in both the MIO-M1 and ARPE-19 cells, this time 
point was used in further experiments. 
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 To test whether the induction of HO-1 was due to cell death, MIO-M1 
cells were subjected to an MTS assay. Cells were serum starved for 24 h, 
followed by incubation with 1-10 µM  SFN for 24 h prior to addition of MTS for 
2.5 h. Controls included a blank, cells on their own and serum starved cells. 
Figure 4.2 demonstrates that SFN did not reduce cell viability at any 
concentration (1, 2, 5 or 10 µM).  This suggests that any effects that may occur 
due to SFN are not as a result of apoptotic/cell death pathways and that the 
SFN does not have cytotoxic effects on the MIO-M1 cells. 
Figure 4.1. SFN induces HO-1 mRNA expression in ARPE-19 and MIO-M1 
cells.  MIO-M1 and ARPE-19 cells were treated with 10 µM of SFN for 0-12 h 
and total RNA extracted. HO-1 mRNA expression was measured by qRT-PCR 
and normalised to GAPDH mRNA expression. Mean + SEM (n=3), *p<0.05, 
**p<0.01, ***p<0.001.  
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To determine if SFN-induction of HO-1 expression was dose-dependent, 
MIO-M1 cells were incubated with 2, 5 or 10 µM SFN for 3 h. Results were 
normalised to GAPDH and the fold inductions were compared to the vehicle 
control (DMSO). Figure 4.3 demonstrates that SFN dose dependently increased 
HO-1 mRNA expression.  Whilst 2 µM SFN slightly increased HO-1 expression, 
this was not significant.  However, 5 µM and, as shown previously, 10 µM SFN 
significantly increased levels of HO-1.   
 
 
 
 
 
 
Figure 4.2. SFN (1-10 µM) does not affect MIO-M1 cell viability. MIO-M1 
cells were treated with 0-10 µM SFN for 24 h before the addition of MTS for  
3 h. Absorbance was measured at 490 nm.  Mean + SEM (n=3).  
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4.3.2 SFN induction of Nrf2 driven genes. 
 As HO-1 is regulated by the transcription factor Nrf2, other ARE/Nrf2 
regulated genes were investigated to discover if they are also upregulated with 
SFN in the MIO-M1 cell line.  The genes investigated were Nrf2 (in case SFN 
induced de novo synthesis), NQO1, ferritin (heavy chain) and Trx1 (1). All 
results were normalised to GAPDH and the fold induction compared to the 
control which included the vehicle control DMSO without SFN.  Nrf2 mRNA is 
basally expressed in MIO-M1 cells, Figure 4.4. (A) demonstrates that SFN did 
not induce Nrf2 mRNA expression in these cells by 12 h. This was not 
Figure 4.3. Induction of HO-1 mRNA expression in MIO-M1 cells is 
concentration-dependent. Cells were treated with 0 – 10 µM SFN for 3 h and 
total RNA extracted. HO-1 mRNA expression was measured by qRT-PCR and 
normalised to GAPDH mRNA expression. Mean + SEM (n=3), p***<0.001.  
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surprising as not many stimuli have been shown to induce Nrf2 de novo 
synthesis, with an exception being LPS in THP-1 cells (Rushworth  et al 2008). 
SFN also did not increase ferritin mRNA expression (Figure 4.4). In fact, ferritin 
mRNA decreased slightly at all time points compared to the control. However, 
the relative CT values were extremely high, which indicated that there was a 
high amount of basal ferritin mRNA expressed, suggesting that ferritin may be 
providing a level of cytoprotection by another means. SFN induced NQO1 
mRNA expression as time progressed, with the 12 h time point showing a 
significant increase in NQO1 levels. The Trx1 CT levels were very low, on the 
border of detection using qRT-PCR, demonstrating very low basal expression of 
this antioxidant enzyme.  This made the results more variable.  There was no 
significant increase in Trx1 mRNA expression following SFN stimulation (Figure 
4.4). 
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Figure 4.4. Effects of SFN on Nrf2-mediated gene expression in MIO-M1 
cells. Cells were treated with 10 µM SFN for 0-12 h and total RNA extracted. 
Nrf2 (A), Ferritin (B), NQO1 (C) and Trx1 (D) mRNA expression was measured 
by qRT-PCR and normalised to GAPDH mRNA expression. Mean + SEM (n=3), 
p**<0.01. 
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 As HO-1 mRNA expression was highly upregulated by SFN, the 
expression of SFN-induced Nrf2 and HO-1 protein expression was investigated. 
MIO-M1 cells, serum starved for 24 h, were treated with SFN for 0, 1, 2, or 4 h 
and total protein extracted. Proteins were separated by SDS PAGE and western 
blot analysis was performed.  The 0 control was also the vehicle control (Figure 
4.5). The results suggested that SFN induced Nrf2 protein expression in a time 
dependent manner. By 1 h Nrf2 protein was present and this continued to 
increase at 2 and 4 h.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5. SFN induces Nrf2 protein expression in MIO-M1 cells.  Cells 
were untreated or treated with 10 µM SFN for 1-4 h and protein extracts 
prepared. Nrf2 protein expression was measured by western blot analysis. 
Figure is a representative of n=3  
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 As HO-1 mRNA expression peaked at 3 h, serum starved MIO-M1 cells 
were incubated with 10 μM SFN for 0-8 h, total protein was extracted and 
proteins separated by SDS PAGE. Western blot analysis demonstrated that 
SFN increased HO-1 protein expression in a time dependent manner. At 4 h 
HO-1 expression was present and by 6 and 8 h the expression was strong.  
 
 
 
 
 
 
 
 
 
 
 
 
 Nrf2 needs to translocate into the nucleus for the upregulation of 
antioxidant genes. Immunocytochemistry was carried out in order to visualise 
the translocation of the Nrf2 protein in MIO-M1 following SFN stimulation. 
Figure 4.7 demonstrates that Nrf2, shown in red, is present following 4 h 
induction with 10 µM SFN; however, translocation in to the nucleus (stained 
blue with DAPI) is not clear.  
 
 
Figure 4.6 SFN induces HO-1 protein expression in MIO-M1 cells.  Cells 
were untreated or treated with 10 µM SFN for 1-8 h and total protein 
extracted. HO-1 protein expression was measured by western blot analysis. 
Representative of n=3.  
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4.3.3 PKC and PI3K regulation of the Nrf2 pathway induced by SFN  
 
 As discussed in Chapter 1, there are several signalling kinases that have 
been associated with the regulation of ARE-driven genes including p38, MAPK, 
PERK, JNK, PI3K and PKC (Ogborne et al 2004, Keum  et al 2006).  Two key 
kinase pathways that have been reported to regulate both sulforaphane-induced 
bioactivity and Nrf2-driven HO-1 expression are PKC and PI3K and these were 
investigated to see if they were involved in the mechanism of action of SFN 
inducing HO-1 in MIO-M1 cells. This was performed using the pan-PKC 
inhibitor, Bisindolylmaleimide I (BIS I) and the PI3K inhibitor LY294002.  MIO-
C 
Figure 4.7 Nrf2 expression (Red) in MIO-M1 SFN stimulation. DAPI is 
shown in blue in all images. A. Sulforaphane 0hrs (no stimulation), B. 10 µM 
Sulforaphane 4h, C. Secondary Antibody Control (Rabbit anti goat)  
 
A                                                     DAPI            B                                                           Nrf2                   
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M1 serum starved cells were either preincubated with 25 µM LY294002 or 10 
µM BIS I for 30 min followed by 10 µM SFN for 3 h. The 0 control was the 
DMSO vehicle control. Figure 4.8 demonstrates that both LY294002 and BIS I 
significantly inhibited SFN induced HO-1 mRNA expression (p*<0.05), whilst 
having minimal effect on reducing the basal levels of HO-1.This indicates that 
PKC and PI3K play a role in the induction of HO-1 by SFN in MIO-M1 cells.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8. Role of PI3K and PKC in SFN-induced HO-1 expression in 
MIO-M1 cells. Cells were pre-treated with 25 µM LY294002 (LY) or 10 µM 
Bisindolylmaleimide I (BIS) for 30 min prior to SFN treatment for 3 h. Total 
RNA was extracted and HO-1 mRNA expression was measured by qRT-PCR 
and normalised to GAPDH mRNA expression. Mean + SEM (n=3) p*<0.05 
p**<0.01.  
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To determine if the effect of BIS I on HO-1 expression was dose-dependent, 
serum starved cells were preincubated with 1, 5 or 10 µM BIS I for 30 min and 
then 10 µM SFN was added to the cells for 3 h.  Controls without SFN added 
were performed to compare the effect that the SFN had on the cells with the 
inhibitors. The 0 control was the DMSO vehicle control. Figure 4.9 
demonstrates that BIS I alone at any concentration had no significant effect on 
basal HO-1 mRNA expression in MIO-M1 cells. However, BIS I significantly 
inhibited SFN-induced HO-1 expression in a dose dependent manner. 1 µM BIS 
I actually enhanced induction of HO-1 mRNA by SFN.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9 Bisindolylmaleimide I dose-dependently inhibits SFN-induced 
HO-1 mRNA expression in MIO-M1 cells. Cells were pre-treated with 1, 5 or 
10 µM Bisindolylmaleimide I (BIS) for 30 min prior to 10 µM SFN treatment for 3 
h. Extracts were  prepared and HO-1 mRNA expression was measured by qRT-
PCR and normalised to GAPDH mRNA expression. Mean + SEM (n=3), 
p***<0.001.  
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 Figure 4.10 shows the effect of preincubation with lower concentrations 
of the PI3K inhibitor LY 294002 on SFN-stimulated HO-1 mRNA expression in 
MIO-M1 cells. Serum starved cells were preincubated with 1, 5, 10 or 25 µM LY 
294002 for 30 min and then 10 µM of SFN was added to the cells for 3 h.  At all 
concentrations, LY294002 alone did not significantly affect the basal expression 
of HO-1 mRNA.  LY294002 significantly reduced SFN-induced HO-1 mRNA 
expression at all concentrations but not in a dose-dependent manner, 
suggesting that it is an on/off switch effect. As 10 µM had the same effect as 25 
µM, 10µM will be used in future experiments as using 25 µM would not be 
specific for PI3K inhibition. 
 
 
 
 
 
 
Figure 4.10 LY294002 dose-dependently inhibits SFN-induced HO-1 
mRNA expression in MIO-M1 cells. Cells were pre-treated with 1, 5, 10 or 25 
µM LY294002 for 30 min prior to 10 µM SFN treatment for 3 h. Extracts were  
prepared and HO-1 mRNA expression was measured by qRT-PCR and 
normalised to GAPDH mRNA expression. Mean + SEM (n=3), p***<0.001.  
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 As inhibition of PI3K and PKC resulted in prevention of SFN induced HO-
1 mRNA expression, the effect of LY294002 and Bisindolylmaleimide I on Nrf2 
and HO-1 protein expression was also investigated. Serum starved cells were 
preincubated with 10 μM BIS  or 10 μM LY294002 for 30 min and then  cells 
were treated with 10 µM  SFN  2 h (for Nrf2 protein) or 8 h (for HO-1 protein). 
Total protein was extracted and separated by SDS PAGE and western blot 
analysis performed. SFN-induced Nrf2 protein expression was highly inhibited 
by both BIS I and LY294002 (Figure 4.11).  SFN-induced HO-1 protein 
expression was also highly inhibited by LY294002 and BIS I (Figure 4.12). 
These results suggest that PKC and PI3K regulate SFN-induced HO-1 
expression, upstream of Nrf2.  
 
 
 
 
 
 
 
 
 
 
   
 
 
 
Figure 4.11 Bisindolylmaleimide I and LY294002 inhibit SFN-induced 
Nrf2 protein expression in MIO-M1 cells. Cells were pre-incubated with 10 
µM LY294002 or 10 µM BIS I for 30 min prior to 10 µM SFN treatment for 2 h 
Total protein extracts were prepared and HO-1 protein expression measured 
by western blot analysis. Representative experiment of n=3.  
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Figure 4.12 Bisindolylmaleimide I and LY294002 inhibit SFN-induced HO-1 
protein expression in MIO-M1 cells. Cells were pre-incubated with 10 µM 
LY294002 or 10 µM BIS I for 30 min prior to 10 µM SFN treatment for 8 h. Total 
protein extracts were prepared and HO-1 protein expression measured by 
western blot analysis. Representative experiment of n=3.  
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4.4 Discussion 
 
  Mueller cells are more resilient to oxidative stress compared to other 
retinal cell types and, through active gliosis, can have protective and cytotoxic 
effects on the surrounding retinal cells (Bringmann et al 2009a). Therefore it is 
important that these cells are protected and maintained to ensure protection of 
the other retinal cell types. Any impairment of the protective functions of Mueller 
cells may contribute to a loss of neurons by increasing their susceptibility to 
oxidative stress in the diseased retina (Tanito et al 2007, Saviranta et al 2011, 
Bringmann et al 2006, Bringmann et al 2009a). The Nrf2 pathway is a central 
co-ordinator of cytoprotective cellular responses. In this study it was shown for 
the first time that SFN can activate the Nrf2 pathway in Mueller cells. SFN 
increased the level of Nrf2 protein in cells but not Nrf2 mRNA expression, 
suggesting that Nrf2 activation was independent of de novo synthesis. In 
addition, SFN activated the Nrf2 target genes, HO-1 and NQO1, but not ferritin 
or Trx1. Furthermore, both PI3K and PKC were involved in the regulation of 
SFN-induced Nrf2 and HO-1 activation. These results demonstrate that the Nrf2 
pathway is activated in Mueller cells and suggest that SFN may have a 
protective function in these cells.  
 SFN has been reported to have numerous beneficial effects in vitro and 
in vivo including chemoprotective, anti-inflammatory, anti-oxidative and 
cytoprotective effects (Tanito et al 2005, Zhang and Tang 2007, Wagner 2011). 
In relation to the eye, previous studies in retinal microglial cells, RPE cells and 
photoreceptor cells have shown that SFN is protective in the retina. It protects 
RPE cells against oxidative stress by upregulating anti-oxidant and Phase II 
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enzymes (Zhou et al 2006, Cano et al  2008). In addition, SFN delays the 
progression of photoreceptor degeneration in mice (Kong et al 2007). This lab 
and others have previously reported that SFN activates HO-1 in monocytes and 
liver, lung and heart cells (Wu et al 2001; Jeong et al 2005, Rushworth et al 
2006, Ping et al 2010, Zhao et al 2010, Wagner et al 2011). However, SFN has 
not previously been reported to activate HO-1 in any retinal cell type. This 
research has shown that SFN activates HO-1 in both ARPE-19 and MIO-M1 cell 
lines, representing retinal pigment epithelial cells and Mueller cells, respectively. 
This could be occurring through modification of the Cys151 residue on Keap1 
where SFN has previously been suggested to activate the Nrf2 pathway (Zhang 
and Hannink 2003). However, this would not take to into account how PI3K and 
PKC inhibition also stopped SFN from inducing HO-1 in these cells. These 
results suggest direct activation of Keap1 by SFN is not the full mechanism of 
action. Further research is required to fully map the exact mechanism of action. 
NQO1 is an enzyme which provides cytoprotection to cells by catalysing 
the detoxiﬁcation of electrophiles and reduces ROS intermediates produced by 
redox cycling. It is a FAD-dependent flavoprotein which reduces, via NADPH or 
NADH, a range of quinines, quinonemines and nitroaromatics (Dinkova-Kostova 
and Talalay 2010). NQO1 has been well documented as being activated by 
SFN, in multiple organs and cell types of mice and humans including the liver, 
lung and the eye. NQO1 has previously been activated in ARPE-19 by the 
antioxidant vitamin E and provided cytoprotection against a chemical found in 
cigarette smoke which has been linked to being a factor in AMD. Also, the citrus 
flavoniod, eriodictyol, another antioxidant has been shown to elevate Nrf2 
driven gene expression in ARPE-19 cells, including NQO1. However, there 
121 
 
have been no reports to date on SFN activating NQO1 in Mueller cells. This 
study demonstrated that SFN significantly activates NQO1 mRNA expression 
after 12 h of induction in the Mueller cell line, MIO-M1 cells. Further studies are 
required to determine if expression is higher at later time points and to examine 
the mechanisms involved, including involvement of Nrf2 and upstream kinases.  
 Excess free iron is a source of oxidative stress (He et al 2007). Within 
the retinal RPE and photoreceptor cells, several iron-containing proteins are 
expressed (Gnana-Prakasam et al 2010). Ferritin, which binds to the cytotoxic 
free iron, has been shown to be induced by SFN in intestine of mice, using 
micro array analysis (Thimmulappa et al 2002, Hintze and Theil 2005). It is 
expressed in the choroid and inner nuclear layer of the retina (He et al 2007). 
Hahn and co-workers have demonstrated that it is expressed in RGC and rod 
bipolar and photoreceptor cells in mice (Hahn et al 2004).  No studies to date 
have reported SFN activation of ferritin expression in Mueller cells.  Ferritin 
consists of two proteins, ferritin H and ferritin L, both of which are regulated by 
Nrf2. Ferritin H usually responds better to Nrf2 stimulation (Hahn et al 2004). In 
this study, it was found that SFN did not induce ferritin H mRNA expression in 
MIO-M1 cells. However, basal ferritin mRNA expression was very high in these 
cells, as evidenced from ferritin CT values in the real-time PCR analysis, 
therefore ferritin may still have a cytoprotective function within Mueller cells but 
not via SFN.  
 Trx1 is a cytoprotective protein that maintains the cells’ normal reduced 
state. Trx1 has been shown to be upregulated by SFN in ARPE-19 cells and 
research has suggested that SFN induces Trx1 through the ARE and provides 
cytoprotection against light damage in whole mice retina and the RPE (Tanito et 
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al 2005). In tubby mice, SFN induces Trx1 expression in photoreceptor cells 
(Kong et al 2009). However, no studies to date have reported SFN activation of 
Trx1 in Mueller cells. This research showed that SFN did not significantly induce 
Trx1 mRNA expression in MIO-M1 cells, and found that the basal levels of Trx1 
mRNA were very low in these cells. However, Trx1 levels did show a trend of 
reducing further by 6 and 12 h, but not by a significant level. This highlights that 
there are potential variations of Nrf2-driven gene expression and induction in 
the different cell types within the retina. As Trx1 is responsible for thiol redox 
control within cells it may be that this type of redox is not required with the 
Mueller cells, but further research would be required to confirm this theory 
(Zhong et al 2000).  
 SFN has been suggested to activate the Nrf2 pathway through Keap1 
modification. As SFN is an electrophile it can potentially interact with thiol 
groups to form thionoacyl adducts, which may affect the cysteine residues on 
Keap1, especially Cys151, but the stability of this within cells is still under 
review (Hu 2011). SFN has previously been shown to not affect Nrf2 mRNA 
levels but upregulates Nrf2 protein over a short period of time (Keum 2011). In 
this study, SFN did not result in Nrf2 de novo synthesis; this was as expected 
as only a few compounds like LPS in THP-1 cells are known to cause Nrf2 de 
novo synthesis (Rushworth et al 2008).  This suggests that SFN may be 
interacting with Keap1, which leads to more Nrf2 protein being available to go 
into the nucleus and increase HO-1 and NQO1 mRNA expression. The free 
Nrf2 protein made available following SFN treatment was shown by 
immunocytochemistry. However, whilst an increase in Nrf2 was seen in the 
cytoplasm it was not clearly seen to be translocating to the nucleus. This may 
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be due to the fact that Nrf2 protein levels started to increase at 1 h and the 
images taken at 4 h missed the translocation but did show that free Nrf2 was 
still present as it is shown by the protein levels. Further experimentation would 
include doing a time course on SFN-induced Nrf2 translocation and using 
confocal microscopy to confirm location in cell. 
Many different pathways and intermediates have been reported to lead to 
activation of Nrf2, including the ERK and p38 MAP kinases, PI3K, PKC, and 
GSK3β. How these different pathways interact to cause Nrf2 activation is still 
under investigation. This study demonstrated that PKC and PI3K aid in the 
regulation of SFN activation of HO-1 and Nrf2 in MIO-M1 cells. PKCδ has been 
reported to activate Nrf2 through tBHQ and dissociate with Keap1 when 
stimulated by antioxidants through Ser40 in HepG2 cells (Bloom and Jaiswal 
2003).  In our laboratory curcumin has shown been to activate Nrf2 through 
PKCδ in THP-1 cells. In the same cell type LPS induces HO-1 expression via 
Nrf2 and PKCα but the subtype is still to be determined (Rushworth et al 2005, 
Rushworth et al 2006). This can lead to the release of Nrf2 from Keap1 leading 
to the upregulation of Nrf2-driven gene expression, including HO-1. In this 
study, inhibiting PKC resulted in the down regulation of SFN induced HO-1 
expression and  total inhibition of Nrf2 protein in the MIO-M1 cells, suggesting 
that it plays an important role in SFN-induced Nrf2 activation. Further studies 
would be required to determine which isoform of PKC were involved, however 
PKCα and PKCδ would be the first two that should be investigated.  
 PI3K has been identified to be a regulatory factor of the Nrf2 pathway 
when activated by a range of dietary antioxidants including carnosyl in PC12 
cells, resveratrol in neurons and the plant extract oleanolic in smooth muscle rat 
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cells (Martin et al 2004, Feng et al 2011, Fukui et al 2010). However, unlike 
PKC no direct phosphorylation of Nrf2 by PI3K has been shown. Wang et al. 
showed that in the ARPE-19 that SFN induced Nrf2 driven genes GCL and GCL 
via PI3K (Wang et al 2008). In this study, LY294002 suppressed SFN-induced 
HO-1 mRNA expression, suggesting that PI3K regulates this pathway. The 
regulation did not appear to be dose-dependent, but was in an on/off switch 
manner, as varying the concentration of the inhibitor did not affect the level it 
reduced HO-1 mRNA expression. However reducing the concentration of the 
inhibitor further may show a dose dependent activation of PI3K. SFN-induced 
HO-1 expression was only partially inhibited with the inhibition of PI3K and HO-
1 expression did not return to basal levels. Lower concentrations of the inhibitor 
were used (1-10 μM) due to 25 μM having the possibility of not being specific 
and could affect other kinase pathways. This suggests that the PI3K pathway is 
only partially responsible for SFN induced HO-1 mRNA expression in MIO-M1 
cells. However, at the protein level inhibition of PI3K did completely prevent 
SFN induced Nrf2 and HO-1 expression. This could mean there are some post 
translational mechanisms activity that is regulated by PI3K. This data suggests 
that PKC and PI3K are both involved upstream of Nrf2 in response to SFN 
stimulation in MIO-M1 cells. More research is required to fully understand the 
complex role that both PI3K and PKC have in the regulation of SFN-induced 
Nrf2 and HO-1 expression in Mueller cells.  Further studies should confirm that 
SFN leads to phosphorylation of these two kinases in MIO-M1 cells, and the 
specific PKC isoform involved could be identified by using a screen of PKC-
specific siRNA or small molecule inhibitors and PKC-specific antibodies. 
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The immunocytochemistry experiments that were conducted in this 
research were preliminary and need to be expanded further by having a large 
range of time points or a live video feed to capture Nrf2 translocating into the 
nucleus. Ideally, confocal microscopy should be used to determine exact 
locations in the cell. Expression of HO-1 and NQO1 could also be investigated 
by immunocytochemistry. Further studies could confirm the involvement of Nrf2 
in SFN-induced HO-1 and NQO1 expression by looking at the translocation of 
Nrf2 into the nucleus by using nuclear and cytosolic extracts and examining by 
western blot analysis, and examining transcriptional activity by reporter assay, 
using a multicopy ARE reporter. In addition, the role of Nrf2 in this pathway 
could be investigated using siRNA knockdown of Nrf2 and functional outcome 
of HO-1 upregulation examined using HO-1 siRNA. 
Finally an interesting way to further this research would be to examine 
this pathway in human organotypic retinal cultures (HORCs), as all reported 
work on the Nrf2 pathway and the retina has been in rat or mice models and not 
in human tissue. Whist Nrf2 had previously been thought to be found in the RPE 
and potentially in the retina no work had looked at Nrf2 expression in Mueller 
cells within the human eye. Expression of SFN- induced Nrf2, NQO1 and HO-1 
would clarify how and where SFN induces Nrf2 driven genes within the retina 
and within the Mueller cells. 
Diet has been linked with age-related retinal associated diseases, 
including AMD and diabetes. Fruit and vegetables contain a multitude of 
flavonoids and other bioactive compounds with anti-oxidant activity. Cucurmin, 
found in the spice turmeric, has been shown to provide cytoprotection against 
light and oxidant stress via the Nrf2 pathway in murine retinas and RPE and 
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photoreceptor cell lines (Mandal et al 2009). Alpha lipoid acid, found in broccoli 
and tomatoes, has been shown to up regulate HO-1 in THP-1 cells (Ogborne et 
al 2005). tBHQ, an anti-oxidant used as a preservative in food has also been 
shown to activate Nrf2 and its downstream genes in primary-cultured 
hepatocytes cells (Keum et al 2006). Further studies could investigate a wide 
range of antioxidants that have the potential to upregulate Nrf2 driven genes in 
Mueller cells and human retinal cultures, to determine their effects on the 
pathway and the functional effects.  
 In conclusion, this research has shown for the first time that the non-toxic 
antioxidant SFN does not induce Ferritin or Trx1 but does induce HO-1 and the 
Nrf2 pathway in human Mueller cells via PKC and PI3K, suggesting that SFN is 
a promising antioxidant that could have therapeutic potential in keeping Mueller 
cells protected from oxidative stress in diseased and healthy retinas. 
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Chapter 5 
General Discussion 
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 Oxidative stress is a major contributing factor in retinal diseases, 
including glaucoma, diabetic retinopathy and AMD (Tezel 2006, Pan et al 2008, 
Zhao 2011) The Nrf2 pathway is a major sensor of oxidative stress, and HO-1 is 
upregulated by most inducers of Nrf2 (Arai-Gaun et al 2004).  The Nrf2 pathway 
plays a key role in the eye by protecting retinal cells from damage. Mueller cells 
are structurally and functionally supportive of the surrounding retinal cells, 
especially neuronal cells, and play a key role in protecting the retina from many 
types of damage (Bringmann et al 2009a). However, the role of the Nrf2 
pathway in Mueller cells has not previously been reported. The studies 
presented here indicate for the first time that the Nrf2 pathway is activated in 
these cells by SFN, a compound from broccoli that has previously been 
reported to have cytoprotective and anti-inflammatory effects in vitro and in vivo 
(Juge et al 2007). In addition, several ROS inducers had no effect on this 
pathway in Mueller cells, suggesting that compared to other cell types in the 
retina, Mueller cells may be more resistant to oxidative stress. 
This study initially looked at the effect of oxidative stress inducers on the 
Nrf2 pathway in the human MIO-M1 cell line, a validated model for retinal 
Mueller cells (Limb et al 2002). Five different inducers were tested on the MIO-
M1 cells, OGD, LPS, high glucose, TNF-α and H2O2, and these have all 
previously been reported to induce ROS in various cell types (Danilov et al 
2009, White et al 2010, Rushworth et al 2011). Further studies should confirm 
that they do indeed induce intracellular ROS in Mueller cells. These 
experiments could be carried out by flow cytometry or a 96-well assay using 
H2DCFDA, a fluorescent dye that detects intracellular ROS. This research 
found that the classical ROS inducer, H2O2, had a minimal effect on HO-1 
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expression in MIO-M1 cells when compared with the ARPE-19 cells (50 fold 
less), suggesting that Mueller cells may be more resistant to oxidative stress. 
Both Mueller cells and RPE have similar roles in the retina, maintaining and 
providing structural support to other more vulnerable cell types (the 
photoreceptors for the RPE and neurons for the Mueller cells). However, the 
current study suggests that the mechanisms involved in performing this role are 
different. It should be noted that MIO-M1 cells have been reported to have 
some stem cell-like properties, which may contribute to a higher resistance to 
oxidative stress and differences between the two cell types.    
In the Mueller and ARPE-19 cells LPS, TNF-α and high glucose 
concentrations had no significant effect on Nrf2, NQO1, ferritin or HO-1 gene 
expression. It should be noted that these are both cell lines, and therefore 
primary human cells may not have the same effect as in the human retina. 
However, this data does contrast with other studies, where LPS has been 
shown to induce mRNA expression of all of these genes in human monocytes 
and the THP-1 monocytic cell line (Rushworth et al 2008 and unpublished data 
from this lab). Injections of LPS into Nrf2 deficient mice eyes to simulate an 
uveitis model up regulated inflammatory and cytokines. When the experiment 
was carried out in wild-type mice these cytokines could be reduced with 
pretreatment of the potent Nrf2 activator 1-(2-cyano-3,12-dioxooleana-1,9(11)-
dien-28-oyl)imidazole by activation of HO-1 and NQO1 (Nagai et al 2009). This 
activator, also known as bardoxolone methyl, is currently in Phase III trials for 
Type II diabetic patients with chronic kidney disease and potentially may be 
useful for DR. The results of this trial are due in 2013 (NCT01351675 Reata 
Pharmaceutical). 
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TNF-α has also been shown to activate HO-1 expression in THP-1 cells 
(Rushworth et al 2011)  and high and varying concentrations of  glucose have 
been associated with the progression of DR. Rat retinas subjected to high levels 
of glucose underwent apoptosis and could be attenuated by GSH (Emery et al 
2011). Although Nrf2 and its downstream target genes are capable of being 
activated in these cell types, the findings of this research suggest that the 
pathway may not be the key component to providing a level of cytoprotection 
from oxidative stress, particularly in the Mueller cells. Additional experiments 
should investigate whether Nrf2 protein expression is upregulated in response 
to these inducers, as it is possible that Nrf2 may be acting through different 
mechanisms, independently of these genes. In addition, it is plausible that 
although mRNA expression is not affected the expression of HO-1, Trx1, NQO1 
and ferritin protein could be upregulated by less degradation occurring and 
therefore this should also be investigated. Overall, though, in accordance with 
other research groups, such as that of Bringmann and co workers, this research 
has found Mueller cells to be less susceptible to and more resilient to oxidative 
stresses induces like OGD and therefore they may be present more often in 
damaged and diseased retina (Bringmann et al 2006, Bringman et al 2009a) 
OGD is a source of oxidative stress in several retinal diseases (Castilho 
et al 2012).  There have been no reports to date on the effect of OGD on MIO-
M1 cells, therefore the findings presented here make an important contribution 
to the understanding of how Mueller cells respond in the diseased retina. A 
clearer understanding of the effects of OGD in Mueller cells and within the 
retina will enable the field to make further advances in understanding the effect 
that OGD has in states of diseases with vascular components including AMD 
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and DR. HORCs could be used in the OGD system to investigate the role of 
Mueller cells in providing cytoprotection.  As HORCs can have blood vessels 
running through them, the way in which the surrounding Mueller cells react 
could be monitored by looking at HIF-1α and VEGF levels by 
immunocytochemistry, mRNA and protein expression. Hif1α and VEGF have 
both been shown to be upregulated in times of OGD. Investigating whether SFN 
could counteract their effects via the Nrf2 pathway in both MIO-M1 cells and 
HORCs could be an interesting line of inquiry. If a positive effect is observed it 
would show how SFN induced Nrf2 activation could be a therapeutic target for 
vascular diseases like AMD and DR.  Also, occasionally HORCs from AMD and 
glaucoma patients are available. Contrast studies using immunocytochemistry 
could be used to monitor different morphological differences if enough donors 
were available. Mueller cells have been reported to release the cytokine TNF-α. 
Measuring the amount of TNF-α released by using an ELISA when Mueller cells 
are under the oxidative stresses OGD, LPS and high glucose could be an 
indicator of gliosis activation. 
The antioxidant SFN has been shown to activate the Nrf2 pathway in 
vitro and in vivo (Juge et al 2007). This is the first study to show that SFN 
activates Nrf2 and its targets HO-1 and NQO1. Further studies are required to 
confirm that NQO1 expression is upregulated in Mueller cells, including longer 
time courses for mRNA expression and ensuring that protein expression is also 
increased.  
The mechanism by which SFN activates the Nrf2 pathway and HO-1 was 
also studied. Using kinase inhibitors, the results suggest that PKC and PI3K are 
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upstream regulators of Nrf2 and are involved in the induction of Nrf2 and HO-1 
in MIO-M1 cells. However, further studies should be carried out to validate 
these results.  The activation of these kinase pathways by SFN should be 
confirmed using phospho-specific antibodies. Both PKC and PI3K kinases are 
actually families of kinases. PKC is a family of Ser/Thr kinases and several 
have been reported to be involved in the activation of Nrf2, including PKCδ and 
PKCα have been shown to directly phosphorylate Nrf2 in vitro. It would be 
interesting to determine which isoforms are involved in this pathway. In addition, 
further studies should be carried out to confirm the involvement of Nrf2 in HO-1 
activation by SFN. DNA-binding assays could be used to confirm that SFN-
induced Nrf2 binds to the ARE in the nucleus of activated cells. In addition, a 
luciferase reporter assay with a HO-1 promoter plasmid could be used to 
confirm that SFN-induced Nrf2 activation results in transcriptional activation of 
the HO-1 promoter. 
Keap1 is a cysteine-rich protein and some activators of Nrf2 have been 
reported to modify several of the cysteine residues, including Cys151. SFN has 
been reported to modify Cys151 (Zhang and Hannink 2003). The involvement of 
Cys151 in SFN activation in Mueller cells could be confirmed by using a small 
peptide to inhibit the interaction of SFN and Keap1. It may also be possible to 
test whether SFN interacts with Keap1 which has had Cys151 deleted out. In 
addition, Nrf2 has been reported to be phosphorylated on Ser40 upon activation 
by the anti-oxidant t-BHQ. This has been reported to be important for the 
dissociation of Nrf2 from Keap1 but not important in its entry into the nucleus 
(Bloom and Jaiswal 2003). A phospho-specific antibody is available and could 
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be used in western blot analysis in response to SFN to examine whether Nrf2 
phosphorylation at Ser40 is involved in this pathway in MIO-M1 cells.  
It is also unclear as to how SFN enters the cells or if it enters the cells at 
all. There could be a receptor involved that activates the PKC and PI3K 
pathways upstream of Nrf2 to activate it. If SFN could be labelled in a way that 
does not affect its function or 3D structure, the exact movements of SFN could 
be monitored. Different labelling methods that could be considered are 
fluorescent labelling or radioactive labelling with immunocytochemistry. Figure 
1.5 shows all the potential mechanism of action that SFN could active HO-1 
through the Nrf2 pathway. 
Not all Nrf2 regulated genes were activated by SFN in these cells. Whilst 
free Nrf2 protein increased with SFN induction, Nrf2 mRNA expression did not 
change, suggesting that SFN does not induce de novo synthesis of Nrf2.  This 
is in agreement with many other activators of Nrf2. In fact, few inducers have 
been shown to affect Nrf2 mRNA levels, but one example is LPS in human 
monocytes (Rushworth et al 2008).  
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Figure 5.1 Potential mechanism of SFN activating HO-1 expression. 
Sulforaphane could activate the Nrf2 pathway through Keap1 directly; with or 
without a receptor activate it through PKC and PI3K. 
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To aid the determination of the functional effects of SFN in the eye and 
retina further studies of SFN in vivo are required. Rat models are a good model 
for performing in vivo studies.  SFN could be administered by diet or directly into 
the eye using drops and injections, then the amount of SFN received in the 
retina could be monitored. The sequential upregulation of Nrf2 driven genes 
could be investigated in the different cell types of the rat retina to determine the 
differences in SFN induced Nrf2 driven genes within a range of retinal cells in 
vivo.  
Nrf2 knockout mice could be utilised to confirm the involvement of Nrf2 in 
the eye. Research has shown that Nrf2 deprived mice are more susceptible to 
DR and AMD.  Studies have looked at the changes within the eye, especially in 
relations to the RPE and AMD; however, much research is still required to look 
at the exact differences between wild type and Nrf2 deficient mice retinal cell 
types and how they are biochemically effected (Zhao et al 2011). HO-1 deficient 
mice could also be used to research the exact effects that HO-1 has in the 
Mueller cells and indeed the other cell types of the retina. Research in this 
manner may give key ideas to the exact effect that Nrf2 and SFN have on the 
retina and mueller cells in an in vivo situation.   
Trx1 plays an important role in the retina by maintaining a reduced state 
within the cells. However, SFN did not induce Trx1 mRNA expression in the 
MIO-M1 cells. This does not mean that Trx1 cannot be induced by other stimuli 
in these cells. Other research has shown Trx1 can act as a reducing agent 
lowering the level of H2O2 in cells (Zhang et al 1997). H2O2 did not induce HO-1 
expression to a significant degree. It is possible that H2O2 would induce Trx1 
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expression as Trx1 mops up peroxides. The basal levels of Trx1 were low but 
further experiments could investigate whether it can be induced by H2O2.  
Gliosis activation has been reported to be both cytotoxic and 
cytoprotective. It has been suggested that low activation of gliosis is 
cytoprotective and higher activation is cytotoxic (Bringmann et al 2009a). The 
mechanistic action by which antioxidants and oxidative stresses activate gliosis 
could be investigated. As GFAP is an indicator of gliosis it can be used to 
measure levels of gliosis activation during stimulation by antioxidant and 
oxidative stress. This would give an indication of the level of gliosis activation. 
Coupling this with MTS assays and TUNEL assays to measure the level of 
cytotoxicity and apoptosis that is occurring in Mueller cells, neurons and RGCs 
could give a more detailed analysis of how gliosis is activated and the effects 
that it has on surrounding cell types. These experiments could be performed in 
HORCs where the effects of antioxidants, oxidative stress, gliosis and the Nrf2 
pathway could be investigated by immunocytochemistry, labelling GFAP and 
Nrf2 and Nrf2 driven genes to see where the Nrf2 pathway is activated. 
 Nrf2 does not have a key role in cytoprotection against oxidative stress in 
Mueller cells. This is an important discovery as it must mean that other 
unknown pathways may be involved. One way to investigate this would be a 
microarray project. Microarrays have been successfully used to characterise the 
activation of many cellular processes. This would use different oxidative stimuli 
on MIO-M1 cells and then screen by microarray for several different genes to 
monitor how they are up and down regulated. This could be a way to finding out 
which are the key pathways involved.  
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Several dietary-derived compounds with anti-oxidant activity have been 
shown to activate the Nrf2 pathway in various cell types and have functional 
effects, including anti-inflammatory and cytoprotective effects. These include α-
lipoic acid from tomatoes and reseverol derived from grapes and wine 
(Scapagnini et al 2002, Ogborne et al 2004,  Rushworth et al 2006). Curcumin 
which is derived from turmeric has been shown to activate the Nrf2 pathway in 
many cell types, including monocytes and RPE cells (Rushworth et al 2006, 
Mandal et al 2009, Woo et al 2012).  As the research presented here shows 
there are differences as to how the RPE and MIO-M1 react to oxidative stimuli 
but that both reacted to SFN in a way that caused the induction HO-1 it would 
be interesting to investigate whether curcumin and other antioxidants also 
upregulated the Nrf2 pathway and HO-1 in a similar fashion.  
SFN is a promising protective agent which has antioxidant, anti-
inflammatory and cytoprotective effects in vivo. The ability to be able to 
upregulate the Nrf2 pathway in long term neurodegenerative and inflammatory 
diseases is a major aspect of current research. With the eye neurodegenerative 
diseases like DR and glaucoma SFN has the potential to be an effective drug. 
However before this can be a true possibility the most effective drug delivery 
system for SFN into the eye needs to be established. The effectiveness of SFN 
to be able to pass through the retina blood barrier would need to be established, 
if effective SFN could be given as a dietary supplement. Drops and gels are 
another potential delivery mechanism as well as injections, which would have a 
less systematic effect. However, the compliance and ease of the patient to take 
the administered SFN would also need to be taken into consideration and the 
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ability of SFN to cross the collagen matrix of the sclera would need to be 
investigated. 
 This research has shown that SFN could have the potential to be an 
exciting new therapeutic for maintaining Mueller cells and the retina. SFN can 
upregulate Nrf2 pathway within the eye and retina. It could be used in a variety 
of eye diseases like AMD, glaucoma, and DR, to slow down the progression of 
these diseases. In addition, this research adds to the knowledge of the nature of 
Mueller cells which could be important in understanding the function of Mueller 
cells in the healthy and damaged retina. 
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